Rui Reis
(3B's Research Group/Univ. Minho, Portugal)

Rui L. Reis, PhD, DSc, Hon. Causa MD, Hon Causa PhD, FBSE, FTERM, member of NAE, FAIMBE, FEAMBES, is a Full Professor of Tissue Engineering, Regenerative Medicine, Biomaterials and Stem Cells at University of Minho (UMinho), Portugal. He is the Founding Director of the 3B’s Research Group and Dean/President of the I3Bs – Institute for Biomaterials, Biodegradables and Biomimetics at UMinho. He is also the CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine and has been the Global President of the Tissue Engineering and Regenerative Medicine International Soc. (TERMIS). He is Associate Editor of PNAS-NEXUS and is in the Editorial Board of several other relevant journals. He co-founded several companies that raised important private investments. His work has been cited more than 98000 times and he is listed in the annual Highly Cited Researchers 2022 and 2023 list from Clarivate. He has been awarded many important international prizes.

Rui Reis
(3B's Research Group/Univ. Minho, Portugal)

Rui L. Reis, PhD, DSc, Hon. Causa MD, Hon Causa PhD, FBSE, FTERM, member of NAE, FAIMBE, FEAMBES, is a Full Professor of Tissue Engineering, Regenerative Medicine, Biomaterials and Stem Cells at University of Minho (UMinho), Portugal. He is the Founding Director of the 3B’s Research Group and Dean/President of the I3Bs – Institute for Biomaterials, Biodegradables and Biomimetics at UMinho. He is also the CEO of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine and has been the Global President of the Tissue Engineering and Regenerative Medicine International Soc. (TERMIS). He is Associate Editor of PNAS-NEXUS and is in the Editorial Board of several other relevant journals. He co-founded several companies that raised important private investments. His work has been cited more than 98000 times and he is listed in the annual Highly Cited Researchers 2022 and 2023 list from Clarivate. He has been awarded many important international prizes.

Milica Radisic
(University of Toronto, Canada)

Dr. Milica Radisic is a Professor at the University of Toronto, Tier 1 Canada Research Chair in Organ-on-a-Chip Engineering and a Senior Scientist at the Toronto General Research Institute. She is also Director of the NSERC CREATE Training Program in Organ-on-a-Chip Engineering & Entrepreneurship and a co-lead for the Center for Research and Applications in Fluidic Technologies. She is a Fellow of the Royal Society of Canada-Academy of Science, Canadian Academy of Engineering, the American Institute for Medical & Biological Engineering, Tissue Engineering & Regenerative Medicine Society as well as Biomedical Engineering Society. She was a recipient of the MIT Technology Review Top 35 Under 35, Queen Elizabeth II Diamond Jubilee Medal, NSERC E.W.R Steacie Fellowship, YWCA Woman of Distinction Award, Killam Fellowship, Acta Biomaterialia Silver Medal, and Humboldt Research Award to name a few. Her research focuses on organ-on-a-chip engineering and development of new biomaterials that promote healing and attenuate scarring. She developed new methods to mature iPSC derived cardiac tissues using electrical stimulation. She is an Executive Editor for ACS Biomaterials Science & Engineering, Senior Consulting Editor for the Journal of Molecular and Cellular Cardiology, a reviewing editor for eLife and a member of the editorial board of another 8 journals. She served on the Board of Directors for Ontario Society of Professional Engineers, Canadian Biomaterials Society and McMaster University Alumni Association. She organized Keystone, EMBO and ECI conferences and numerous sessions at TERMIS and BMES meetings. She served as a Scientific Officer for the Canadian Institutes of Health Research and member of review panels for CIHR, NIH and Israel Ministry of Education. She is the Chair of Investment Committee for Serbia Innovation Fund. She is a co-founder of two companies TARA Biosystems (acquired by Valo Health), that uses human engineered heart tissues in drug development and safety testing, and Quthero that advances regenerative hydrogels. Her work has been presented in over 260 publications, garnering over 20,000 citations with an h-index of 71. Her publications appeared in Cell, Nature Materials, Nature Methods, Nature Protocols, Nature Communications, PNAS etc.

Changyou Gao
(Zhejiang University, China)

Changyou Gao graduated from Department of Chemistry, Jilin University to get his Bachelor degree (1990), Master degree (1993) and Ph.D of Polymer Chemistry and Physics (1996). From 1996 to 1998, he worked in Department of Polymer Science and Engineering of Zhejiang University as a postdoctor fellowship. He was a DAAD and visiting scholar in Germany (1999). He is a Cheung Kong Scholar of Ministry of Education of China, a winner for the National Science Fund for Distinguished Young Scholars of China, a fellow of the international federation of biomaterial science and engineering societies, the American Institute of Medicinal and Biological Engineering, Royal Society of Chemistry, and Chinese Society of Biomaterials. He is now serving as an associate president of Chinese Society of Biomaterials, and an associate editor of Biomaterials Advances and Progress in Materials Science. His research interests include self-adaptive biomaterials, immuno-modulation biomaterials, anti-bacterial biomaterials and their applications in tissue repair and regeneration. He has published more than 500 papers with an H-index of 78.

Laura Poole-Warren
(The University of New South Wales, Australia)

Laura is a Professor in Biomedical Engineering at UNSW and leads a research group focussed on design and development of novel materials for neural electrodes and other soft-tissue interfaces, and on 3D engineered neural tissue models. A key theme of her work is on understanding material and device compatibility with cells and tissues. Throughout her career, she has worked across academia, industry, and government. She was a research professor at the New Jersey Centre for Biomaterials based at Rutgers University in the USA and a preclinical scientist in the biomedical industry working on development of wound dressings and embolic agents for cancer treatment from 1999 to 2001. She also served from 2003 to 2013 as a member of the Australian Government Therapeutic Goods Administration statutory expert committee on the safety of medical devices. Between 2005 and 2018, Laura held various leadership appointments at UNSW as Pro Vice-Chancellor, and Dean of Graduate Research, as well as being the Australian representative on the International Union of Societies of Biomaterials Science and Engineering. She was awarded honours in January 2020 as a Member of the Order of Australia (AM) for service to Biomedical Engineering and education, is a Fellow of three academies, FTSE, FAIMBE and FBSE and the Royal Society of NSW

Bikramjit Basu
(Indian Institute of Science, Bangalore, India)

Dr. Bikramjit Basu is a Professor at the Indian Institute of Science, Bangalore, India, since 2011 and earlier served on the faculty of the Indian Institute of Technology Kanpur (2001-2011). He has been pursuing research at the confluence of Materials Science, Additive Manufacturing, Biological Science, and Medicine, to address many unanswered questions related to regenerative engineering and reconstructive surgeries. His research group has effectively applied the principles and tools of these disciplines to develop next-generation implants and bioengineering solutions to address unmet clinical needs for musculoskeletal, dental, and neurosurgical applications; thereby impacting human healthcare. His research group has developed technologies related to the manufacturing of bioceramics, acetabular liners, customized bone flaps for cranioplasty surgeries, dental implants and variants of hydrogels. These technologies are transferred to multinational corporates or start-ups, and many of the products, after regulatory clearances, are currently used for patient care in India.
A Chartered Engineer of the UK, he has the unique distinction of being the only ceramic scientist from India to get elected to all the major international societies and academies, including the World Academy of Ceramics (2024), the European Ceramic Society (2023), the American Ceramic Society (2019). In India, he is the only engineering scientist to get elected as a Fellow of all the National Academies of Engineering, Science and Medicine, including the Indian National Science Academy (2021), Indian Academy of Sciences (2020), American Ceramic Society (2019), National Academy of Medical Sciences (2017), Indian National Academy of Engineering (2015), and National Academy of Sciences, India (2013). Internationally, he is an elected fellow of the International Union of Societies for Biomaterials Science and Engineering (2020), International Academy of Medical and Biological Engineering (2017) and the American Institute of Medical and Biological Engineering (2015). He is a recipient of India’s most prestigious Science and Technology award, Shanti Swarup Bhatnagar Prize (2013) from the Prime Minister of India; and globally competent awards, like Humboldt Research Award from the Alexander von Humboldt foundation (2022), and International Richard Brook Award from the European Ceramic Society (2022). He is currently serving on many advisory panels of the national institutes, European university and federal funding agencies as well as major multinational corporates. As the current President of the Society for Biomaterials and Artificial Organs India (1000+ members across India, US and Europe) and in his leadership roles as the Chair of Bioceramics Division and other principal committees of the American Ceramic Society (ACerS), he has brought transformative changes to significantly enhance international visibility of the biomaterials programs in different countries, while inspiring several hundreds of young researchers in Bioceramics area across the world. Such activities together with his roles as the lead investigator in several multi-institutional network programs including multicentric clinical studies enabled creating a vibrant translational ecosystem, to bring together key stakeholders (industry professionals and clinicians) on the innovation platform in India.

Seung-Woo Cho
(Yonsei University, Korea, Republic of)

Seung-Woo Cho is a professor at the Department of Biotechnology at Yonsei University, Republic of Korea. He obtained his B.S.,M.S., and Ph.D. degrees at the School of Chemical Engineering of Seoul National University in 1999, 2001, and 2006, respectively. He received his postdoctoral training at the Department of Chemical Engineering in the Massachusetts Institute of Technology. He later joined Yonsei University as a faculty member in 2010 and has been appointed as Underwood Distinguished
Professor since 2020. His research interests include engineering stem cells, reprogrammed cells, and organoids with functional biomaterials and devices for tissue engineering, disease modeling, and drug screening.

James Moon
(University of Michigan, Ann Arbor, USA)

Dr. James Moon is John Gideon Searle Professor in the Department of Pharmaceutical Sciences, Biomedical Engineering, and Chemical Engineering at the University of Michigan, Ann Arbor. His interdisciplinary research program aims to develop novel biomaterials-based strategies to advance fundamental understanding of the immune system, with the ultimate goal of improving patients’ lives with effective vaccines and immunotherapies. Dr. Moon has published over 120 research articles, including those published in Nature Materials, Nature Medicine, Nature Nanotechnology, Nature Biomedical Engineering, Nature Reviews Materials, and Science Translational Medicine. He has over 20 pending/approved U.S. and international patent applications, and his novel nano-vaccine delivery technologies have led to 3 new start-up companies (EVOQ Therapeutics, Saros Therapeutics, and Elicio Therapeutics). Dr. Moon is a fellow of BMES, AIBME, and CRS, and his contributions to the field has been recognized with numerous awards, including NSF CAREER Award and Samyang CRS Award. Dr. Moon received his bachelor’s degree from the University of California, Berkeley (2002), and his Ph.D. from Rice University (2008), and he completed his postdoctoral training at MIT. He joined the faculty of the University of Michigan in 2012.

Sing Yian Chew
(Nanyang Technological University, Singapore)

Dr. Sing Yian CHEW is a Professor at the School of Chemistry, Chemical Engineering and Biotechnology, the Lee Kong Chian School of Medicine and the School of Materials Science and Engineering at Nanyang Technological University, Singapore. She is known for her contributions in designing biomimetic scaffolds to understand and control cell fate. Dr. Chew’s most significant contribution is in the field of scaffold-mediated delivery of gene-silencing and biomimicking physical signals for neural tissue regeneration and remyelination. Specifically, her lab engineers bio-functional platforms for long-term delivery of biologics. These scaffolding constructs may be used for understanding and directing neural tissue regeneration after traumatic injuries, stem cell fate and host-implant integration. Since joining NTU, Dr. Chew has continued to embark on scientific learning and exchanges by serving as visiting scholar/professor at Johns Hopkins University, University of Edinburgh, INSERM (U698 and U791); University of Paris 13; University of Nantes; Jinan University in Guangzhou, China; Wyss Institute at Harvard. She is an Associate Editor at ACS Applied Materials & Interfaces. She also serves as the editorial board member of Biomaterials, Experimental Neurology, Tissue Engineering, Journal of Biomedical Materials Research, Part A, Drug Delivery and Translational Research, Journal of Tissue Engineering.

Elizabeth Cosgriff Hernandez
(University of Texas at Austin, USA)

Elizabeth Cosgriff-Hernandez, Ph.D. is a Professor of Biomedical Engineering at The University of Texas at Austin and holder of the Cullen Trust for Higher Education Endowed Professorship in Engineering. She received a B.S. in Biomedical Engineering and Ph.D. in Macromolecular Science and Engineering from Case Western Reserve University and then completed a UT-TORCH Postdoctoral Fellowship at Rice University with a focus in orthopaedic tissue engineering. Dr. Cosgriff-Hernandez joined the faculty of the Biomedical Engineering Department at Texas A&M University in 2007 prior to moving to The University of Texas at Austin in 2017. Her laboratory specializes in the development of polymeric biomaterials to improve clinical outcomes of medical devices and regeneration strategies. She is a co-founder of Rhythio Medical, on the scientific advisory board of ECM Biosurgery, and a consultant to several companies on biostability evaluation of medical devices. Dr. Cosgriff-Hernandez is an Associate Editor of the Journal of Materials Chemistry B and Fellow of the International Union of Societies for Biomaterials Science and Engineering, Biomedical Engineering Society, Royal Society of Chemistry, and the American Institute for Medical and Biological Engineering. She has previously served as an Associate Editor of the Journal of Biomedical Materials Research, Part B and chair of the NIH study section on Musculoskeletal Tissue Engineering.

Lorenzo Moroni
(Maastricht University, Netherlands)

Prof. Dr. Lorenzo Moroni studied Biomedical Engineering at Polytechnic University of Milan, Italy, and Nanoscale Sciences at Chalmers Technical University, Sweden. He received his Ph.D. cum laude in 2006 at University of Twente on 3D scaffolds for osteochondral regeneration, for which he was awarded the European doctorate award in Biomaterials and Tissue Engineering from the European Society of Biomaterials (ESB). In 2007, he worked at Johns Hopkins University as a post-doctoral fellow in the Elisseeff lab, focusing on hydrogels and stem cells. In 2008, he was appointed the R&D director of the Musculoskeletal Tissue Bank of Rizzoli Orthopedic Institute, where he investigated the use of stem cells from alternative sources for cell banking, and the development of novel bioactive scaffolds for skeletal regeneration. From 2009 till 2014, he joined again University of Twente, where he got tenured in the Tissue Regeneration department.
Since 2014 he works at Maastricht University, where he is a founding member of the MERLN Institute for Technology-Inspired Regenerative Medicine. In 2016, he became full professor in biofabrication for regenerative medicine. Since 2019, he is chair of the Complex Tissue Regeneration department. He was vice-director of MERLN from 2019 till 2022. Since 2022, he is director of MERLN.
His research group interests aim at developing biofabrication technologies to generate libraries of 3D scaffolds able to control cell fate, with applications spanning from skeletal to vascular, neural, and organ regeneration. From his research efforts, 3 products have already reached the market. In 2014, he received the prestigious Jean Leray award for outstanding young principal investigators from the ESB and the ERC starting grant. In 2016, he also received the prestigious Robert Brown Award for outstanding early career principal investigators from TERMIS. In 2017, he was elected as faculty of the Young Academy of Europe and in the top 100 Italian scientists within 40 worldwide by the European Institute of Italian Culture. He has been elected as member of the Science Academy of Europe since 2022.

Khoon Lim
(University of Sydney, Australia)

Associate Professor Khoon Lim is currently an Australian Research Council Future Fellow and the Director of the Light Activated Biomaterials research group at the University of Sydney, Australia. Khoon is a biomedical engineer with specialization in polymer chemistry. He completed a concurrent degree - Bachelors (Hons 1) in Chemical Engineering and Masters in Biomedical Engineering, followed by a PhD in Biomedical Engineering (graduated 2014) from the University of New South Wales. He then went to join the Department of Orthopedic Surgery and Musculoskeletal Medicine at the University of Otago Christchurch in New Zealand for a postdoctoral fellowship, where he established the Light Activated Biomaterials (LAB) research group in 2019. In 2022, he joined the University of Sydney. His research focus is on adopting a class of polymers known as hydrogels as tissue engineering matrices for a variety of applications. His has developed a number of research technology platform, primarily using photo-polymerizable hydrogel bioinks for 3D bioprinting of functional tissues and also delivery of bioactive molecules to promote tissue regeneration. He has generated multiple high impact journal publications (Chemical Reviews, Advanced Materials, Advanced Functional Materials), and raised a total of >$7.8 Million research grant funding with $5.4 Million as lead Chief-Investigator. He has won >20 competitive national/international awards and included in the World’s Top 2% Scientist List by Stanford University for 2022 and 2023. His research has also led to commercialisation of biomaterials licensed to a US-based company and commercial contracts with industry partners. His research has also generated a number of intellectual property and patent applications, including a full utility patent now granted in China, Australia, America and Europe, where he’s the lead inventor. He is also involved in a number of collaborative projects involving national and international collaborators (Germany, Netherlands, Australia, China and Scotland). He is the current President of the Australasian Society for Biomaterials and Tissue Engineering, Board Member of the International Society for Biofabrication, and Executive Board Member of the New Zealand Medical Technology Research Acceleration Programme. He also serves on a number of editorial boards including RSC Biomaterials Science, Biofabrication, Macromolecular Bioscience, International Journal of Bioprinting, Tissue Engineering: Part B, Biomedical Physics and Engineering Express and Journal of Materials Science: Materials in Medicine.

Nicholas Dunne
(Dublin City University, Ireland)

Nicholas Dunne is the Full Professor of Biomaterials Engineering and holds Executive Directorship for the Medical Engineering Research Centre and Biodesign Europe at Dublin City University (Ireland). Prof Dunne's research programme lies at the interface of materials science, engineering and biology, and his group focuses in the development of stratified approaches for the design, manufacture and characterisation of drug-biomaterial combination medical devices for efficacious hard and soft tissue repair and regeneration. This work spans fundamental mechanisms at the host/material interface as well as translational research to target non-union bone defects, bone metastases and chronic wounds. This research programme has been developed via a strong, interdisciplinary research programme complimented with over-arching international research institute and industry collaborations.

Joachim Kohn
(Rutgers University/IUSBSE, USA)

Joachim Kohn, PhD, FBSE is a national leader in the field of biomaterials science. As founding director of the New Jersey Center for Biomaterials (NJCBM) for 22 years and as Head of the Laboratory for Biomaterials Research at Rutgers, Prof. Kohn has made seminal contributions to the design and commercialization of new biomaterials for regenerative medicine, tissue engineering and drug delivery. He pioneered the use of combinatorial and computational methods for the optimization of polymer properties for use in medical implants (including a coronary stent and an antimicrobial device to prevent infections in pacemaker patients). These implants are being used by over one million patients and are currently approved in 46 countries. As a translational scientist, Prof Kohn has 78 issued US Patents on novel biomaterials and seven companies have licensed his technologies. He is the scientific founder of three spin-off companies. Dr Kohn retired from Rutgers in 2020 and remains active in research, entrepreneurship and the biomaterials community. He was elected President of the International Union of Societies for Biomaterials Science and Engineering in 2020.

Selected Recent Honors and Awards
2022 Recipient of the Award for Distinguished Contribution in Advancement of Biomaterials Science, given by the Japanese Society for Biomaterials
2022 Recipient of the International Award by the European Society for Biomaterials
2020 Recipient of the National Award in Applied Polymer Science by the American Chemical Society.
2019 Recipient of the 2019 Society for Biomaterials Founders Award for life-time achievements in biomaterials science.
2018 Recipient of the 2018 Healthcare Heroes Award for outstanding contributions to the advancement of biomaterials-based therapies.
2017 Recipient of the 2017 Thomas Alva Edison Patent Award for best patent in biomaterials in New Jersey presented by the Research and Development Council of New Jersey.

Ana Paula Pego
(i3S / INEB - University of Porto, Portugal)

Ana Paula Pêgo got her Ph.D. in Polymer Chemistry and Biomaterials from the University of Twente, the Netherlands, in 2002. In 2003 she moved to INEB – Instituto de Engenharia Biomédica, where she became a Principal Investigator in 2012. In 2015, INEB joined the i3S – Instituto de Investigação e Inovação em Saúde (Universidade do Porto), where Ana Paula Pêgo leads the nanoBiomaterials for Targeted Therapies (nBTT) Group.

By using nanomedicine strategies the nBTT Group, aims at providing in situ and in a targeted manner the required signals to promote nervous tissue regeneration. The research on new biomaterials for application in neurosciences includes the development of new polymers for the design of alternative vectors to viruses for efficient nucleic acid delivery, the preparation of nerve grafts for spinal cord injury treatment and the design of brain tissue engineered platforms. Societal and ethical issues that concern Regenerative Medicine and NanoMedicine are also topics in which Ana Paula Pêgo is involved.

She has been appointed the Scientific Director of the Bioimaging Centre for Biomaterials and Regenerative Therapies of INEB and she is an Invited Associate Professor at the Instituto de Ciências Biomédicas Abel Salazar (ICBAS) of the University of Porto.

Currently Ana Paula Pêgo is a member of the Board of Directors of i3S, being the Head of Strategy & Creation of Value Unit, serves as an Associate Editor of Biomaterials (Elsevier journal) and is part of the Board of Reviewing Editors of Science (AAAS).

Ana Paula Pêgo served two terms in the European Society for Biomaterials (ESB) Council, being the ESB Council Secretary from 2017-2021 and the ESB President from 2021-2023, being now the ESB past President.

Diego Mantovani
(Laval University, Canada)

Professor in biomaterials, scientist in regenerative medicine, holder of the Canada Research Chair Tieur I in biomaterials and bioengineering for the innovation in surgery, Diego Mantovani is en expert in nanocoatings, biodegradable metals and 3D cell culture for advanced in vitro tests alternative to in vivo. With his team, he carried out R&D&I projects often in collaboration with companies to unravel how sciences and engineering can improve the patient quality of life of Humans, and to develop new processes for improving the clinical performances of commercial devices, as well as exploring new strategies for tomorrow's clinical therapies. Focus is on cardiac, peripheral, cerebral, dental and parenchymal tissue. The Lab is based at ULaval, in the beatiful nordic city of Quebec, labelled UNESCO treasure, in the French-living part of Canada. He was elected Fellow of the International Union of Societies of Biomaterials since 2012, of the American Society for Materials Intl since 2016, the American Institute of Medical Biological Engineering since 2019, and of the Canadian Academy of Engineering since 2020. He was executive Co-Chair of the 10th World Biomaterials Congress, held in Montréal, Canada, in 2016, May.

Ines Goncalves
(i3S - Institute for Research and Innovation in Health, Portugal)

Inês C. Gonçalves is Principal Investigator at i3S – Instituto de Investigação e Inovação em Saúde, and Leader of the Advanced Graphene Biomaterials Group. She is co-founder of the Start-Up GOTech Antimicrobial, and board member of the Iberian Society of Biomechanics and Biomaterials (SIBB). From 2010 to 2021 she was invited professor at University of Porto (FEUP and at ICBAS), teaching in Bioengineering Masters.
IG is a Microbiologist with PhD in Biomedical Engineering. She focuses on the development of graphene biomaterials and medical devices for antimicrobial and cardiovascular applications, ranging from fundamental science to translational applications.
She has been involved in 20 research projects (12 as principal investigator), in the organization of 21 national/international conferences (10 as scientific committee and 11 as organizing committee) and participates in initiatives at i3S that aim to provide primary school children a first contact with science.
Inês C. Gonçalves is the author of 42 papers in peer reviewed international journals (H-index 23, 1827 citations; source: Scopus ID 7006107771) and 4 book chapters, and has 5 filled patents (1 already granted). Her work was presented as over 70 oral communications and over 50 posters in international conferences. She has supervised/co-supervised 4 Post-Docs (2 ongoing), 12 research assistants (1 ongoing), 5 PhD students (2 ongoing) and 15 MSc students (3 ongoing).
Her work has been recognized with several national and international awards, including "Pulido Valente Science Prize”, the "Medal of Honor L'Oreal for Women in Science", and recently the “Innovator Award” from Wellcome Trust.

Andrés J. García
(Georgia Institute of Technology, USA)

Andrés J. García is the Executive Director of the Petit Institute for Bioengineering and Bioscience and Regents’ Professor at the Georgia Institute of Technology. Dr. García’s research program integrates innovative engineering, materials science, and cell biology concepts and technologies to create cell-instructive biomaterials for regenerative medicine and generate new knowledge in mechanobiology. This cross-disciplinary effort has resulted in new biomaterial platforms that elicit targeted cellular responses and tissue repair in various biomedical applications, innovative technologies to study and exploit cell adhesive interactions, and new mechanistic insights into the interplay of mechanics and cell biology. In addition, his research has generated intellectual property and licensing agreements with start-up and multi-national companies. He is a co-founder of 3 start-up companies (CellectCell, CorAmi Therapeutics, iTolerance). He has received several distinctions, including the NSF CAREER Award; the Young Investigator Award, the Clemson Award for Basic Science, and the Founders Award from the Society for Biomaterials; the International Award from the European Society for Biomaterials; and Georgia Tech’s Outstanding Interdisciplinary Activities Award and the Class of 1934 Distinguished Professor Award. He is an elected Fellow of Biomaterials Science and Engineering (by the International Union of Societies of Biomaterials Science and Engineering), Fellow of the American Association for the Advancement of Science, Fellow of the American Society of Mechanical Engineers, and Fellow of the American Institute for Medical and Biological Engineering. He served as President for the Society for Biomaterials in 2018-2019. He is an elected member of the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors.

Nan Huang
(Southwest Jiaotong University, China)

Nan Huang is professor of Biomaterials at the Department of Materials Sciences and Engineering of Southwest Jiaotong University, China. He leads a group specialized in cardiovascular biomaterials, surface modification and implantable and interventional devices. He has published over 1000 papers in international journals. And obtained over 100 patents. One kind of stent was developed by his team with both excellent anticoagulation and anti-restenosis properties. Until now about 400 thousands of patients have been accepted the intervention with this stent in clinic in China and the complications was significant lower than other kinds of stnets.
Prof. Nan Huang has been the Fellow of the International Union of Societies for Biomaterials Science & Engineering since 2008, and is the Chairman of the International Committee of the International Symposium on surfaces and the Interfaces of Biomaterials since 2007.

Matteo Santin
(University of Brighton, United Kingdom)

Prof Matteo Santin is Professor of Tissue Regeneration at the School of Applied Sciences, University of Brighton, UK, and the Director of the Brighton Centre for Regenerative Medicine and Devices. His career in biomedical research and teaching started in 1989 and it has been marked by significant achievements that were internationally recognised in 2005 by the European Society for Biomaterials who conferred him the Jean Leary Award, elected him as a member of the board (2009-2013) and as the President of the Society (2013-2017). He is the founder and director of 2 start-up companies with a mission in biomaterials, Brighton Wound Care Ltd and Tissue Click Ltd.
His scientific interests include natural biomaterials, synthetic biomimetic nano-structured biomaterials able to control tissue regeneration and biosensing. He has developed in vitro clinically-reflective models for the testing of nanomedicines, biomaterials and tissue engineering constructs. He has published over 100 peer-reviewed papers, over 200 presentations at international conferences, filed 11 patents applications and unveiled for the first time the biochemical and cellular mechanisms of inflammatory response to silk fibroin, new cellular mechanisms leading to the failure of cardiovascular stents and the tissue regeneration potential of novel soybean-based biomaterials and biomimetic dendrimers (i.e. hyperbranched molecules able to control cell functions and tissue regeneration).

Samantha Zambuto
(Washington University in St. Louis, USA)

Dr. Samantha Zambuto is currently a T32 postdoctoral fellow in the Clinical Outcomes Research Training Program in Female Lower Urinary Tract Disorders at Washington University in St. Louis. She is dual affiliated with both biomedical engineering and obstetrics and gynecology and is co-advised by Dr. Michelle Oyen PhD and Dr. Jerry Lowder MD. Prior to coming to Washington University in St. Louis, she received her PhD from University of Illinois Urbana-Champaign under the guidance of Dr. Brendan Harley (Dissertation: ‘Biomaterial-based Models of the Endometrium and Trophoblast Invasion to Investigate Early Pregnancy’). She received her bachelor’s degree in biological engineering from Cornell University, her master’s degree in biomedical engineering from Brown University, and her Master of Population Health Sciences from the Washington University School of Medicine. She is deeply committed to improving health equity in science and seeks to use engineering techniques to understand pregnancy, child birth, and the female reproductive system by creating sophisticated tissue engineered models of the endometrium and vagina. She will join the Department of Mechanical and Aerospace Engineering at University of Kentucky in January 2025 as an Assistant Professor.

Samantha Zambuto
(Washington University in St. Louis, USA)

Dr. Samantha Zambuto is currently a T32 postdoctoral fellow in the Clinical Outcomes Research Training Program in Female Lower Urinary Tract Disorders at Washington University in St. Louis. She is dual affiliated with both biomedical engineering and obstetrics and gynecology and is co-advised by Dr. Michelle Oyen PhD and Dr. Jerry Lowder MD. Prior to coming to Washington University in St. Louis, she received her PhD from University of Illinois Urbana-Champaign under the guidance of Dr. Brendan Harley (Dissertation: ‘Biomaterial-based Models of the Endometrium and Trophoblast Invasion to Investigate Early Pregnancy’). She received her bachelor’s degree in biological engineering from Cornell University, her master’s degree in biomedical engineering from Brown University, and her Master of Population Health Sciences from the Washington University School of Medicine. She is deeply committed to improving health equity in science and seeks to use engineering techniques to understand pregnancy, child birth, and the female reproductive system by creating sophisticated tissue engineered models of the endometrium and vagina. She will join the Department of Mechanical and Aerospace Engineering at University of Kentucky in January 2025 as an Assistant Professor.

Juan Gnecco
(Tufts University, USA)

Dr. Juan Gnecco is Colombian-American scientist and an Assistant Professor in the Dept. of Biomedical Engineering at Tufts University. He is the principal investigator of the Laboratory of Reproductive Engineering and an associate principal investigator in the Mother Infant Research Institute (MIRI) at Tufts Medical Center. His overarching research vision lies at the interface of women’s health and engineering to understand the immune-endocrine mechanisms driving both reproductive physiology and disease pathogenesis. As a trained reproductive biologist with extensive experience in bioengineering, he merges interdisciplinary approaches to dissect the complex and dynamic nature of the female reproductive tract. Dr. Gnecco first obtained a B.S. in Biotechnology from Rutgers University followed by a Ph.D in Cellular and Molecular Pathology from Vanderbilt University Medical Center (VUMC). He then conducted his post-doctoral training at Massachusetts Institute of Technology (MIT) where he led efforts to transform the human clinical relevance of 3-dimensional (3D) reproductive tract models. He has been awarded three rounds of funding from Gates Foundation (2018-present) for his work building phenotypic screening models of the female reproductive tract. He is the consortium lead for the World Endometriosis Research Foundation (WERF) consortium to unify experimental organoid models, and was selected as a Rising Star in Engineering and Health by Columbia University (2020)

Samantha Zambuto
(Washington University in St. Louis, USA)

Dr. Samantha Zambuto is currently a T32 postdoctoral fellow in the Clinical Outcomes Research Training Program in Female Lower Urinary Tract Disorders at Washington University in St. Louis. She is dual affiliated with both biomedical engineering and obstetrics and gynecology and is co-advised by Dr. Michelle Oyen PhD and Dr. Jerry Lowder MD. Prior to coming to Washington University in St. Louis, she received her PhD from University of Illinois Urbana-Champaign under the guidance of Dr. Brendan Harley (Dissertation: ‘Biomaterial-based Models of the Endometrium and Trophoblast Invasion to Investigate Early Pregnancy’). She received her bachelor’s degree in biological engineering from Cornell University, her master’s degree in biomedical engineering from Brown University, and her Master of Population Health Sciences from the Washington University School of Medicine. She is deeply committed to improving health equity in science and seeks to use engineering techniques to understand pregnancy, child birth, and the female reproductive system by creating sophisticated tissue engineered models of the endometrium and vagina. She will join the Department of Mechanical and Aerospace Engineering at University of Kentucky in January 2025 as an Assistant Professor.

Michelle Oyen
(Washington University in St. Louis, USA)

Michelle L. Oyen is the inaugural Director of the new Center for Women’s Health Engineering at Washington University in St. Louis. She is based in the department of Biomedical Engineering. Prior to her current appointment, she was on the faculty at the University of Cambridge (2006–18) in the UK and then briefly at East Carolina University (2018–21). Michelle has degrees in Materials Science and Engineering (BS), Engineering Mechanics (MS), and a PhD in Biophysical Sciences. Her research primarily concerns problems in tissue biomechanics and biomimetic materials. She has researched engineering approaches to pregnancy and women’s health for over twenty years, particularly in methods to prevent, diagnose, and intervene in preterm birth. Current research projects include multi-scale modeling of placenta function, microstructural fracture models for amniotic sac rupture, and physical properties of the healthy and pathological uterus.

Kaitlin Fogg
(Oregon State University, USA)

Dr. Kaitlin Fogg is an Assistant Professor of Chemical, Biological, and Environmental Engineering at Oregon State University, where her research is focused on gynecological disease modeling. She completed her B.S. in Chemical and Biological Engineering from the University of Wisconsin-Madison and her Ph.D. in Biomedical Engineering at the University of California, Davis in 2016, with a research emphasis on tissue engineering. Following her doctoral studies, Dr. Fogg returned to the University of Wisconsin-Madison for a postdoctoral fellowship, where she used in vitro models of disease and statistical modeling techniques to unravel the intricate interactions between the immune system and ovarian cancer.

Her contributions to the field have earned her prestigious recognitions, including a pre-doctoral fellowship from the American Heart Association, a Scientific Scholar award from the Rivkin Center for Ovarian Cancer Research, and recognition as a Shooting Star at the 2018 Cellular and Molecular Bioengineering Conference. Currently, Dr. Fogg's research focuses on engineering complex models of gynecological diseases that are specifically designed for high throughput drug screening. These models serve as a valuable platform for studying signaling dynamics, identifying potential therapeutic targets, and enabling the rapid evaluation of innovating treatment approaches. This research is supported by an NIGMS R35, an NIEHS R01, and an industry partnership with Hewlett-Packard (HP). Additionally, Dr. Fogg is in the seed stage of establishing a biotech company whose mission is to build an expansive library of advanced drug screening platforms tailored specifically for gynecological diseases.

Minjeong Jang
(Korea Institute of Radiological Medical Sciences, Korea, Republic of)

Korea Advanced Institute of Science and Technology (KAIST), Ph.D., 2019
Korea Institute of Science and Technology (KAIST), Post.Doc., 2020~2023
Korea Institute of Radiological & Medical Sciences (KIRAMS), Senior Researcher, 2023~

Brendan Harley
(University of Illinois at Urbana-Champaign, USA)

Professor of Chemical and Biomolecular Engineering at the University of Illinois at Urbana-Champaign.

Brendan Harley
(University of Illinois at Urbana-Champaign, USA)

Professor of Chemical and Biomolecular Engineering at the University of Illinois at Urbana-Champaign.

Elizabeth Cosgriff Hernandez
(University of Texas at Austin, USA)

Elizabeth Cosgriff-Hernandez, Ph.D. is a Professor of Biomedical Engineering at The University of Texas at Austin and holder of the Cullen Trust for Higher Education Endowed Professorship in Engineering. She received a B.S. in Biomedical Engineering and Ph.D. in Macromolecular Science and Engineering from Case Western Reserve University and then completed a UT-TORCH Postdoctoral Fellowship at Rice University with a focus in orthopaedic tissue engineering. Dr. Cosgriff-Hernandez joined the faculty of the Biomedical Engineering Department at Texas A&M University in 2007 prior to moving to The University of Texas at Austin in 2017. Her laboratory specializes in the development of polymeric biomaterials to improve clinical outcomes of medical devices and regeneration strategies. She is a co-founder of Rhythio Medical, on the scientific advisory board of ECM Biosurgery, and a consultant to several companies on biostability evaluation of medical devices. Dr. Cosgriff-Hernandez is an Associate Editor of the Journal of Materials Chemistry B and Fellow of the International Union of Societies for Biomaterials Science and Engineering, Biomedical Engineering Society, Royal Society of Chemistry, and the American Institute for Medical and Biological Engineering. She has previously served as an Associate Editor of the Journal of Biomedical Materials Research, Part B and chair of the NIH study section on Musculoskeletal Tissue Engineering.

Jenny Robinson
(University of Washington, USA)

Dr. Jenny Robinson is an Assistant Professor in Orthopaedics and Sports Medicine and Mechanical Engineering and Core Faculty in the Institute for Stem Cell and Regenerative Medicine at the University of Washington. There she holds the Endowed Chair in Women’s Sports Medicine and Lifetime Fitness. Jenny received her B.S. and Ph.D. in Biomedical Engineering from Rice University and Texas A&M University, respectively. Dr. Robinson completed her postdoctoral fellowship in Biomedical Engineering and Craniofacial Biology at Columbia University. Dr. Robinson was previously an Assistant Professor in Chemical Engineering and the Bioengineering Graduate Program at the University of Kansas prior to her move to the University of Washington. Her research has been recognized by a NIH NIGMS R35 MIRA award, a Biomaterials Science Emerging Investigator issue award, a AIChE Futures Journal award, Rosalind Franklin Society/Mary Ann Liebert Award, and delegate to the National Academy of Engineering Frontiers Symposium.

Brendan Harley
(University of Illinois at Urbana-Champaign, USA)

Professor of Chemical and Biomolecular Engineering at the University of Illinois at Urbana-Champaign.

Brian Aguado
(University of California San Diego, USA)

Dr. Brian Aguado (Twitter: @BrianAguado) is currently an Assistant Professor of Bioengineering at UC San Diego, where his laboratory research is focused on studying sex differences in cardiovascular disease using biomaterial technologies. Dr. Aguado completed his BS degree in Biomechanical Engineering from Stanford University and his MS and PhD in Biomedical Engineering from Northwestern University. He also obtained his certificate in Management for Scientists and Engineers from the Kellogg School of Management at Northwestern. He completed his postdoctoral fellowship in Chemical and Biological Engineering at the University of Colorado Boulder. Dr. Aguado has received the NIH K99/R00 Pathway to Independence Award, the American Heart Association Career Development Award, the Chan Zuckerberg Initiative Science Diversity Leadership Award, and the NIH DP2 New Innovator Award to support his sex differences research. Dr. Aguado currently serves on the editorial advisory boards for the Journal of Biomedical Materials Research Part A, GEN Biotechnology, and Frontiers in Bioengineering. Dr. Aguado is also a dedicated science communicator outside of the lab and enages historically excluded and marginalized populations in the sciences. Dr. Aguado co-founded LatinXinBME (Twitter: @LatinXinBME), a 501(c)(3) non-profit organization dedicated to building a diverse and inclusive community of Latinx biomedical engineers and scientists to support each other personally and professionally through their careers. For his efforts, he was named one of the 100 Most Inspiring Latinx Scientists in America by Cell Press and received the Biomaterials Diversity Award for Young Investigator from the Biomaterials journal and the GEMINI Faculty Mentor Award from the Institute for Engineering in Medicine.

Brian Aguado
(University of California San Diego, USA)

Dr. Brian Aguado (Twitter: @BrianAguado) is currently an Assistant Professor of Bioengineering at UC San Diego, where his laboratory research is focused on studying sex differences in cardiovascular disease using biomaterial technologies. Dr. Aguado completed his BS degree in Biomechanical Engineering from Stanford University and his MS and PhD in Biomedical Engineering from Northwestern University. He also obtained his certificate in Management for Scientists and Engineers from the Kellogg School of Management at Northwestern. He completed his postdoctoral fellowship in Chemical and Biological Engineering at the University of Colorado Boulder. Dr. Aguado has received the NIH K99/R00 Pathway to Independence Award, the American Heart Association Career Development Award, the Chan Zuckerberg Initiative Science Diversity Leadership Award, and the NIH DP2 New Innovator Award to support his sex differences research. Dr. Aguado currently serves on the editorial advisory boards for the Journal of Biomedical Materials Research Part A, GEN Biotechnology, and Frontiers in Bioengineering. Dr. Aguado is also a dedicated science communicator outside of the lab and enages historically excluded and marginalized populations in the sciences. Dr. Aguado co-founded LatinXinBME (Twitter: @LatinXinBME), a 501(c)(3) non-profit organization dedicated to building a diverse and inclusive community of Latinx biomedical engineers and scientists to support each other personally and professionally through their careers. For his efforts, he was named one of the 100 Most Inspiring Latinx Scientists in America by Cell Press and received the Biomaterials Diversity Award for Young Investigator from the Biomaterials journal and the GEMINI Faculty Mentor Award from the Institute for Engineering in Medicine.

Jane Grande-Allen
(Rice University, USA)

Dr. Grande-Allen is Professor of Bioengineering and Associate Dean for Faculty Development in the School of Engineering at Rice University.

Jenny Robinson
(University of Washington, USA)

Dr. Jenny Robinson is an Assistant Professor in Orthopaedics and Sports Medicine and Mechanical Engineering and Core Faculty in the Institute for Stem Cell and Regenerative Medicine at the University of Washington. There she holds the Endowed Chair in Women’s Sports Medicine and Lifetime Fitness. Jenny received her B.S. and Ph.D. in Biomedical Engineering from Rice University and Texas A&M University, respectively. Dr. Robinson completed her postdoctoral fellowship in Biomedical Engineering and Craniofacial Biology at Columbia University. Dr. Robinson was previously an Assistant Professor in Chemical Engineering and the Bioengineering Graduate Program at the University of Kansas prior to her move to the University of Washington. Her research has been recognized by a NIH NIGMS R35 MIRA award, a Biomaterials Science Emerging Investigator issue award, a AIChE Futures Journal award, Rosalind Franklin Society/Mary Ann Liebert Award, and delegate to the National Academy of Engineering Frontiers Symposium.

Juan Gnecco
(Tufts University, USA)

Dr. Juan Gnecco is Colombian-American scientist and an Assistant Professor in the Dept. of Biomedical Engineering at Tufts University. He is the principal investigator of the Laboratory of Reproductive Engineering and an associate principal investigator in the Mother Infant Research Institute (MIRI) at Tufts Medical Center. His overarching research vision lies at the interface of women’s health and engineering to understand the immune-endocrine mechanisms driving both reproductive physiology and disease pathogenesis. As a trained reproductive biologist with extensive experience in bioengineering, he merges interdisciplinary approaches to dissect the complex and dynamic nature of the female reproductive tract. Dr. Gnecco first obtained a B.S. in Biotechnology from Rutgers University followed by a Ph.D in Cellular and Molecular Pathology from Vanderbilt University Medical Center (VUMC). He then conducted his post-doctoral training at Massachusetts Institute of Technology (MIT) where he led efforts to transform the human clinical relevance of 3-dimensional (3D) reproductive tract models. He has been awarded three rounds of funding from Gates Foundation (2018-present) for his work building phenotypic screening models of the female reproductive tract. He is the consortium lead for the World Endometriosis Research Foundation (WERF) consortium to unify experimental organoid models, and was selected as a Rising Star in Engineering and Health by Columbia University (2020)

Seung-Woo Cho
(Yonsei University, Korea, Republic of)

Seung-Woo Cho is a professor at the Department of Biotechnology at Yonsei University, Republic of Korea. He obtained his B.S.,M.S., and Ph.D. degrees at the School of Chemical Engineering of Seoul National University in 1999, 2001, and 2006, respectively. He received his postdoctoral training at the Department of Chemical Engineering in the Massachusetts Institute of Technology. He later joined Yonsei University as a faculty member in 2010 and has been appointed as Underwood Distinguished
Professor since 2020. His research interests include engineering stem cells, reprogrammed cells, and organoids with functional biomaterials and devices for tissue engineering, disease modeling, and drug screening.

Shelly Sakiyama-Elbert
(University of Washington, USA)

Shelly Sakiyama-Elbert, Ph.D. is the Vice Dean for Research and Graduate Education in the University of Washington School of Medicine and Professor of Bioengineering. She earned a S.B. in chemical engineering and biology from Massachusetts Institute of Technology, and a M.S. and Ph.D. from California Institute of Technology. She joined the faculty at Washington University in Biomedical Engineering in 2000 as an Assistant Professor, where she advanced to the position of the Joseph and Florence Farrow Professor of Biomedical Engineering and Vice Dean for Research in the School of Engineering. She served as Department Chair and Professor of Biomedical Engineering at the University of Texas at Austin from 2016- 2022.
Her research program focuses on developing biomaterials for drug delivery and cell transplantation for the treatment of peripheral nerve and spinal cord injury. She was Co-Director of the Center of Regenerative Medicine, as well as a member of the Institute of Materials Science and Engineering at Washington University. Her honors include Senior Scientist Award -TERMIS AM (2023), Fellow of the National Academy of Inventors (2017), Society for Biomaterials Clemson Award for Basic Research (2017), Outstanding Faculty Mentor from the WU Graduate Student Senate (2015), WU Distinguished Faculty Award (2013), and WU Dean’s Award for Excellence in Advising and Mentoring (2008). She was elected Fellow of the International College of Fellows in Biomaterials Science and Engineering in 2016, the American Association for the Advancement of Science (AAAS) in 2015, the Biomedical Engineering Society (BMES) in 2013, and the and the American Institute for Medical and Biological Engineering (AIMBE) in 2011.

Hala Zreiqat
(University of Sydney, Australia)

Hala Zreiqat, is a Payne-Scott Professor of biomedical engineering at The University of Sydney. The focus of her lab is on engineering functional synthetic biomaterials for use in regenerative medicine using cutting-edge materials, biological and nano techniques, and novel 3D-printing technologies.

Prof. Zreiqat’s contribution to regenerative medicine and orthopaedic research has led to a number of national and international awards, including being named a Member of the Order of Australia (2019), 2021-2022 Fulbright Senior Scholar; Laureate for the TAKREEM Foundation 2022 “Scientific & Technological Achievement”; the 2018 New South Wales Premier’s Woman of the Year, the King Abdullah II Order of Distinction of the Second Class (2018), Radcliffe Fellow at Harvard University (2016-2017); Eureka Prize winner for Innovative Use of Technology (2019); and University of Sydney Payne-Scott Professorial Distinction (2019). She is also a Fellow of the Australian Academy of Sciences (2021); the Australian Academy of Technology & Engineering (2020), the International Association of Advanced Materials (2022), the Royal Society of New South Wales (2019); Australian Academy of Health and Medical Sciences (2019), and the International Orthopaedic Research Society (2019). She is the past president of the Australian & New Zealand Orthopaedic Research Society. She was the Director of the Australian Research Council Training Centre for Innovative BioEngineering (2017-2022) and a National Health and Medical Research Council Senior Research Fellow (2006-2020). She is the Chair of the Council for Australian-Arab Relations (CAAR) (2020-2023); an Associate of the John A. Paulson School of Engineering and Applied Sciences at Harvard University and an Honorary Professor at Shanghai Jiao Tong University.

Prof. Zreiqat has authored over 180 peer-reviewed publications with over 10,000 citations. Her research in the field of musculoskeletal disorders and biomaterials research has led to four awarded and four provisional patents and more than $20.5M in competitive funding, including major grants from the National Health and Medical Research Council, Australian Research Council and the New South Wales Medical Devices Fund.
As well as her pioneering work in biomaterials development, Prof. Zreiqat is committed to improving opportunities for women and young scientists around the world. She is the founder and Chair of the BIOTech Futures, a science and engineering mentorship program for high school students.

Sung Yun Yang
(Chungnam National University, Korea, Republic of)

Sung Yun Yang received her B.S and M.S. from Ewha Womans University in 1991 and 1993, respectively. After serving in the Chemistry division at KRICT and KIST, in 1995 moved to USA for her doctoral degree in Polymer Chemistry and Engineering at Polytechnic University, New York University currently. In August of 2000, she moved to MIT as a postdoctoral researcher in the Department of Materials Science and Engineering. She worked in a biotech company for a year and returned to Korea in 2004 starting her professorship at Chungnam National University. Since 2004 she has been with CNU, is now a professor of Organic Materials Engineering. Along with her research and academic activity, she also served as a vice-president of the Center for Women in Science, Engineering and Technology to promote educational opportunity for woman engineers. Prof. Yang’s research interests include functional nanomaterials for energy, environmental sustainability, and biomedical application.

Maria Chatzinikolaidou
(Foundation for Research and Technology Hellas (FORTH) Institute of Electronic Structure and Laser 100, Greece)

Dr. Maria Chatzinikolaidou, FBSE, FTERM, is an Associate Professor of Biomaterials in Bioengineering and Head of the Laboratory for Biomaterials in Tissue Engineering at the Department of Materials Science and Technology at the University of Crete (https://www.materials.uoc.gr/el/general/personnel/mchatzin.html), and affiliated faculty member at Foundation for Research and Technology – Hellas (FORTH). Her research interests focus on the development of biomaterials and scaffolds for tissue engineering applications including bone, dental, cardiovascular, and the validation of their in vitro and in vivo biocompatibility, functionality and biomechanical characteristics.
Dr. Chatzinikolaidou is actively involved in several competitive national and international projects, is author of >90 publications in international peer-reviewed journals, 4 book chapters, >180 peer-reviewed conference abstracts, and inventor of 4 patents on osteoinductive implants. She was elected member of the Executive Board of the Hellenic Society for Biomaterials and served as vice president in the terms 2015-2018 and 2022-now. She served as chair of the 28th Conference of the European Society for Biomaterials (ESB 2017) held in Athens, and program chair of the TERMIS-EU 2019 conference held in Rhodes in Greece. She is a Fellow in Biomaterials Science and Engineering (FBSE, elected 2020) of the International Union of Societies for Biomaterials Science and Engineering (IUS-BSE) and International Fellow of Tissue Engineering and Regenerative Medicine (FTERM, elected 2023). Since 2022 she is member of the Nomination Committee of Tissue Engineering and Regenerative Medicine International Society (TERMIS) EU chapter. She is an editorial board member in Tissue Engineering, Frontiers in Bioengineering and Biotechnology, Regenerative Biomaterials, Frontiers in Bioengineering and Biotechnology, Journal of Materials Science Materials in Medicine etc. She teaches lectures on Biomaterials, Cell Biology and Biochemistry, and Tissue Engineering in undergraduate and graduate courses at the University of Crete and other Universities in Grece, and is currently supervisor of four PhD candidates and three Master’s students.

Hyuk Sang Yoo
(Kangwon National University, Korea, Republic of)

He received a B.S. degree (1996), a M.S. degree (1998), and a Ph.D. degree (2002, Advisor: Professor Tae Gwan Park) at Department of Biological Sciences, Korea Advanced Institute of Science and Technology. After a post-doctoral fellow at Department of Biomedical Engineering, the Johns Hopkins University (2004, Advisor: Professor Kam W. Leong), he joined the Kangwon National University as an assistant professor (2005). He is now a tenured professor of Biomedical Materials Engineering. He was also a visiting scholar for the Johns Hopkins University (2005) and the Northwestern University (2010). His research is focused on nano-biomaterials for drug delivery and tissue engineering employing multifunctional nanofibers and nanoparticles.
Http://nano-bio.kangwon.ac.kr

Hyuk Sang Yoo
(Kangwon National University, Korea, Republic of)

He received a B.S. degree (1996), a M.S. degree (1998), and a Ph.D. degree (2002, Advisor: Professor Tae Gwan Park) at Department of Biological Sciences, Korea Advanced Institute of Science and Technology. After a post-doctoral fellow at Department of Biomedical Engineering, the Johns Hopkins University (2004, Advisor: Professor Kam W. Leong), he joined the Kangwon National University as an assistant professor (2005). He is now a tenured professor of Biomedical Materials Engineering. He was also a visiting scholar for the Johns Hopkins University (2005) and the Northwestern University (2010). His research is focused on nano-biomaterials for drug delivery and tissue engineering employing multifunctional nanofibers and nanoparticles.
Http://nano-bio.kangwon.ac.kr

Katja Schenke-Layland
(Eberhard Karls University Tubingen, Germany)

Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine at the Medical Faculty of the University Tübingen (MFT). She is the Director of the NMI Natural and Medical Sciences Institute in Reutlingen, the CEO of the NMI-TT GmbH, and the Study Dean of Medical Technologies at the University of Tübingen. Katja is currently the Co-Editor-In-Chief of Tissue Engineering Part B (Mary Ann Liebert) and Executive Editor of Advanced Drug Delivery Reviews (Elsevier), as well as on several editorial boards such as Matrix Biology (Elsevier), Current Opinion in Biomedical Engineering (Elsevier), and Journal of 3D Printing in Medicine (Future Medicine). Katja is a fellow/ board member of the German National Academy of Science and Engineering (acatech), the German Central Ethics Committee for Stem Cell Research (ZES), International and German Societies of Matrix Biology, and the European Alliance for Medical and Biological Engineering and Science (EAMBES). She has published more than 190 peer-reviewed articles, has an h-index of 51 (Scopus), and has been granted 4 patents.

Katja Schenke-Layland
(Eberhard Karls University Tubingen, Germany)

Katja Schenke-Layland is the Professor of Medical Technologies and Regenerative Medicine at the Medical Faculty of the University Tübingen (MFT). She is the Director of the NMI Natural and Medical Sciences Institute in Reutlingen, the CEO of the NMI-TT GmbH, and the Study Dean of Medical Technologies at the University of Tübingen. Katja is currently the Co-Editor-In-Chief of Tissue Engineering Part B (Mary Ann Liebert) and Executive Editor of Advanced Drug Delivery Reviews (Elsevier), as well as on several editorial boards such as Matrix Biology (Elsevier), Current Opinion in Biomedical Engineering (Elsevier), and Journal of 3D Printing in Medicine (Future Medicine). Katja is a fellow/ board member of the German National Academy of Science and Engineering (acatech), the German Central Ethics Committee for Stem Cell Research (ZES), International and German Societies of Matrix Biology, and the European Alliance for Medical and Biological Engineering and Science (EAMBES). She has published more than 190 peer-reviewed articles, has an h-index of 51 (Scopus), and has been granted 4 patents.

Fan Yang
(Stanford University School of Medicine, USA)

Fan Yang is an Associate Professor with tenure at Stanford University with joint appointments in the Departments of Bioengineering and Orthopaedic Surgery, and Director of Stanford Stem Cells and Biomaterials Engineering Laboratory. Her research seeks to develop hydrogels with unique design at micro- and nano- scales to modulate stem cell differentiation, tissue regeneration and immunomodulation, with applications focus on musculoskeletal diseases. Her lab also harnesses biomaterials to create 3D cancer models with in vivo-mimicking phenotype and drug responses. Such 3D models could enable discovering novel druggable targets that would otherwise be missed using conventional 2D culture, and enable high-throughput drug screening with reduced cost and time than animal models. Prior to joining Stanford, Dr. Yang received her Ph.D. in Biomedical Engineering from Johns Hopkins University, and then completed a postdoctoral fellowship at MIT under Prof. Robert Langer. In recognition of her innovation, she has been recognized by numerous awards including Fellow of American Institute for Medical and Biological Engineering, MIT TR35 Global list honoree, National Science Foundation CAREER award, Young Investigator Award from Society for Biomaterials, Biomaterials Science Lectureship Award, Young Investigator award from Alliance for Cancer and Gene Therapy, Ellen Weaver Award by the Association for Women in Science, Baxter Faculty Scholar Award, the McCormick Faculty Award, Stanford Asian American Faculty Award, and the Basil O’Connor Starter Scholar Research Award.

Byeongmoon Jeong
(Ewha Womans University, Korea, Republic of)

Byeongmoon Jeong received his B.S. (1987) in the Department of Chemistry from Seoul National University, M.S (1989) from KAIST, and his Ph.D. (1999) in the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah. He worked at the Pacific Northwest National Laboratory, USA as a senior research scientist before joining Ewha Womans University in 2002. He has authored 150 international peer-reviewed papers and patents on stimuli-sensitive polymers; particularly related to biodegradable thermogels. His publications have been cited 17,000 times during the last decade. He received an Achievement Award in the Polymer Division of Korean Chemical Society (2010), Hanwha Polymer Award from Polymer Society of Korea (2021), Osstem Implant Biomaterials Grand Prize from Korean Society for Biomaterials (KSBM) (2022). His research concentrates on stimuli-sensitive hydrogels and their applications for drug delivery and tissue engineering. He is also serving as vice president of KSBM and editor in cheif of Biomaterials Research, an official journal of KSBM.

Michaela Muehlberg
(Royal Society of Chemstry (RSC), United Kingdom)

Dr Michaela Muehlberg is Executive Editor for the RSC’s Materials & Nano portfolio including Materials Horizons, Journals of Materials Chemistry A, B and C, Nanoscale Horizons and Nanoscale. She has been with the Royal Society of Chemistry since 2014 working on a variety of RSC journals including RSC Advances, Chemical Communications and Organic & Biomolecular Chemistry. Previous to that she studied chemistry at the Free University of Berlin, Germany and Université Paris-Sud, France, and obtained a PhD in bioorganic chemistry from the Free University of Berlin, Germany.

Jurica Bauer
(Maastricht University, Netherlands)

Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.

Jurica Bauer
(Maastricht University, Netherlands)

Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.

Young Jung No
(The University of Sydney, Australia)

Dr Young No is a biomaterials engineer, Lecturer (US: Assistant Professor) and Deputy Head of School (Education) at the School of Biomedical Engineering at the University of Sydney, and also served as acting Associate Dean (Learning and Teaching) at the Faculty of Engineering in early 2023. Dr No was also awarded “40 under 40 Most Influential Asian-Australian for 2022” by the Asian-Australian Leadership Summit for his leadership in biomedical engineering programs at the University of Sydney, shaping the curriculum to be the most comprehensive in the southern hemisphere in terms of topics and areas covered to match the rapidly rising importance and relevance of biomedical engineering in the modern-day technological setting. His innovative and engaging teaching practices in his classes have been well-recognised, with multiple commendations received for his courses, teaching awards, and being featured in university videos for World Teachers’ Day in 2023. Dr No has also led and contributed significantly to biomedical engineering outreach, resulting in significantly increased interest in biomedical engineering amongst prospective students and subsequently increased number of students pursuing biomedical engineering at the University of Sydney for their professional careers.

Dr No’s area of research is in the engineering and characterising novel synthetic bioactive materials for musculoskeletal applications, with primary focus on developing novel cements and ceramic composites. He has published 17 peer-reviewed journal articles, with all publications in journals ranked in the top 30% (Scimago Journal Rank) in the fields of materials science and biomedical engineering, including in high impact journals in the field, and has two published patents as primary co-inventor. His research on the synthetic biomaterials has been the subject of multiple successful grant applications, including the Australian Research Council Linkage Grant as well as other grants including the University of Sydney Commercial Development and Industry Partnership Fund, Australia–Germany Joint Research Co-operation Scheme (DAAD), and Harvard Mobility Scheme. YJN’s work has also been recognised for impact and won presentation awards in conferences including the Australia New Zealand Orthopaedic Research Society (ANZORS), and TERMIS-AP.

Johnna S. Temenoff
(Georgia Tech and Emory University, USA)

Dr. Johnna S. Temenoff is the Carol Ann and David D. Flanagan Professor the Coulter Department of Biomedical Engineering at Georgia Tech/Emory University. She is also currently the Director of the NSF Engineering Research Center in Cell Manufacturing Technologies (CMaT) and the Director of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Scientifically, Dr. Temenoff is interested in scaling culture of therapeutic cells and tailoring the molecular interactions between glycosaminoglycans and proteins/cells for use in regenerative medicine applications. Her laboratory focuses primarily on promoting repair after injuries to the tissues of the shoulder, including cartilage, tendon, and muscle.

Jurica Bauer
(Maastricht University, Netherlands)

Dr. Jurica Bauer graduated in chemistry from the University of Zagreb, Croatia, where he developed a passion for research and teaching. Having worked as medicinal chemist at GlaxoSmithKline for a few years, he moved to The Netherlands to pursue a PhD degree in the field of molecular motors and machines with Professor Feringa at the University of Groningen. As a postdoctoral researcher in the group of Professor Broer at the Eindhoven University of Technology and in collaboration with Philips, he developed a smart liquid-crystalline polymer coating for LEDs to fine-tune the properties of emitted light. In 2014 he was appointed Lecturer in Chemistry at the Inholland University of Applied Sciences in Amsterdam where he developed a new Polymer Chemistry minor and acted as graduation and internationalization coordinator. In 2020 he joined the MERLN Institute at the Maastricht University as Assistant Professor of Education to coordinate the design and development of a new undergraduate study program in the field of Regenerative Medicine and Technology. He is also involved in ongoing teaching and research activities within the institute. His interests include innovation and research in STEM education and scientific research in the field of smart, and especially photoresponsive, nanobiomaterials for medicinal applications.

Young Jung No
(The University of Sydney, Australia)

Dr Young No is a biomaterials engineer, Lecturer (US: Assistant Professor) and Deputy Head of School (Education) at the School of Biomedical Engineering at the University of Sydney, and also served as acting Associate Dean (Learning and Teaching) at the Faculty of Engineering in early 2023. Dr No was also awarded “40 under 40 Most Influential Asian-Australian for 2022” by the Asian-Australian Leadership Summit for his leadership in biomedical engineering programs at the University of Sydney, shaping the curriculum to be the most comprehensive in the southern hemisphere in terms of topics and areas covered to match the rapidly rising importance and relevance of biomedical engineering in the modern-day technological setting. His innovative and engaging teaching practices in his classes have been well-recognised, with multiple commendations received for his courses, teaching awards, and being featured in university videos for World Teachers’ Day in 2023. Dr No has also led and contributed significantly to biomedical engineering outreach, resulting in significantly increased interest in biomedical engineering amongst prospective students and subsequently increased number of students pursuing biomedical engineering at the University of Sydney for their professional careers.

Dr No’s area of research is in the engineering and characterising novel synthetic bioactive materials for musculoskeletal applications, with primary focus on developing novel cements and ceramic composites. He has published 17 peer-reviewed journal articles, with all publications in journals ranked in the top 30% (Scimago Journal Rank) in the fields of materials science and biomedical engineering, including in high impact journals in the field, and has two published patents as primary co-inventor. His research on the synthetic biomaterials has been the subject of multiple successful grant applications, including the Australian Research Council Linkage Grant as well as other grants including the University of Sydney Commercial Development and Industry Partnership Fund, Australia–Germany Joint Research Co-operation Scheme (DAAD), and Harvard Mobility Scheme. YJN’s work has also been recognised for impact and won presentation awards in conferences including the Australia New Zealand Orthopaedic Research Society (ANZORS), and TERMIS-AP.

Jeong-Kee Yoon
(Chung-Ang University, Korea, Republic of)

Dr. Jeong-Kee Yoon is an associate professor in the Department of Systems Biotechnology at Chung-Ang University, Republic of Korea. He received his Ph.D. degree from Seoul National University, Republic of Korea in 2017, and worked as a postdoctoral researcher at Georgia Institute of Technology until 2021. His research interests are at the interface of regenerative medicine and biomedical engineering, primarily focused on vascular engineering using stem cells, engineered exosomes, and 3D cell culture methods for tissue regeneration and disease modeling. He has published 51 peer-reviewed articles, and is a co-inventor on two registered patents. In terms of education, he teaches Organic Chemistry, Biomaterials, and Biomedical Engineering to undergraduates of non-engineering majors, and Tissue Engineering and Regenerative Medicine to graduate students. He has been selected twice (in 2022 and 2023) as a Teacher of Excellence at Chung-Ang University based on surveys completed by 70-80 students per class.

Christine Knabe
(Philipps University Marburg, Germany)

Professor Christine Knabe is Professor of Experimental Orofacial Medicine at the dental school of the Philipps University Marburg, Germany. The focus of her work is on translational research from bench to bedside in the context of clinically relevant subjects in regenerative medicine and biomaterials research. Her research deals with various aspects of regenerative medicine, bone regeneration and bone tissue engineering utilizing bioactive resorbable bone grafting materials and 3D printed bioactive ceramic scaffolds in combination with 3D perfusion stem cell culture and microvascular techniques for segmental defect repair mainly in the context of implant dentistry and orthopaedics. From 1999 on, Professor Knabe built her own independent research program, specifically focusing on cellular reaction pathways triggered by the presence of bioactive implant materials and on translational research, which takes new biomaterials and therapeutic concepts for bone and tissue regeneration from basic research via preclinical studies involving large animal models and clinical trials to the clinical arena. These studies led to the FDA approval and clinical use of a novel bioactive silica containing calcium orthophosphate bone grafting material. Professor Knabe’s work furthermore deals with the effect of host factors on craniofacial bone regeneration with bioactive calcium phosphate bone grafts. This is in addition to collaborating with colleagues at University of Pennsylvania in the pursuit of much better treatments of resistant infections and with colleagues of the UNC at Charlotte on novel bioceramic urethral bulking agents.
Prof. Knabe obtained her DDS at the University of Göttingen, Germany, in 1988, and her PhD with Professor U. Gross in Berlin, Germany. After training in Oral Surgery and Periodontology at the University of Tübingen, she joined the Department of Prostodontics at the Free Universität Berlin in 1992. She complemented her training by various study periods abroad. In 1993, with Professor J. E. Davies at the University of Toronto, Canada; and in 1994. with Professor U. Belser at the University of Geneva, Switzerland, in clinical implant dentistry. From 1992-2010, she held various positions with increasing responsibilities in the departments of Prosthodontics (1992-1996), Periodontology (1996-1997), and was director of the division of Biomaterials and Dental Materials of the Dept. of Experimental Dentistry (1997-2010) at the Charité University Medical Center. 1999-2000 she spent a sabbatical with Prof. Rolfe Howlett at the Bone Biomaterial Unit of the University of New South Wales in Sydney, Australia to study molecular biological issues regarding implant-tissue interactions. Since 2007 she also has been visiting associate professor at the Division of Orthopaedic Surgery of the Thomas Jefferson University in Philadelphia (Director Prof. I. Shapiro). In January 2011, she joined the Philipps University Marburg, where she chairs the department of Experimental Orofacial Medicine. A very recent honor received by Professor Knabe from the Charité Foundation is the appointment as BIH (Berlin Institute of Health) visiting professor. In this context, Prof. Knabe closely collaborates with colleagues at the Charité University Medical Center and the Federal Institute for Materials Research in the pursuit of tissue engineered approaches for reconstruction of large segmental mandibular discontinuity defects resulting from tumor ablation.

Ahmed El-Ghannam
(University of North Carolina at Charlotte, USA)

Dr. El-Ghannam is a highly creative biomaterials engineer with several US patents on the design of novel bioactive resorbable ceramics, coating bioceramics on Titanium and cobalt-chromium alloy and additive manufacturing of SiC and SCPC for space, military, and medical applications. The laboratory of Dr. EL-Ghannam got funds from DePuy J&J company, North Carolina Biotechnology center, DoD, NASA and others. Dr. El-Ghannam has successfully taken a novel resorbable bioactive ceramic (Shefabone SCPC) from the laboratory bench to the surgery room through FDA approval. He has many collaborators from universities, industry and medical institutes in US and worldwide. Dr. El-Ghannam has been a keynote speaker and a chair in national and international biomaterials conferences and has served as the associate editor of the JBMR-A for the last 16 years. He authored and co-authored biomaterials books and book chapters and have many publications in biomedical materials, engineering, dental and orthopedic journals. He was recognized recently by Stanford University in the list of the top 2% most widely cited scientists in Bioengineering.

Min Wang
(Department of Mechanical Engineering, The University of Hong Kong, Hong Kong SAR, China)

Min Wang earned his BSc (1985) and PhD (1991) degrees in Materials Science and Engineering at Shanghai Jiao Tong University, China, and University of London, U.K., respectively. Dr.Wang is a tenured professor at The University of Hong Kong (HKU) since 2008. He has also been a Guest Professor or Adjunct Professor of several universities in mainland China (Shanghai Jiao Tong University, Zhejiang University, Tianjin University, Southwest Jiaotong University, South China University of Technology, etc.). As Programme Director, he led HKU’s interfaculty Medical Engineering Programme in 2013-2018. He is now an elected member of HKU’s Senate. Prior to joining HKU in 2003, Dr.Wang conducted research and teaching in universities in the UK (1991-1997), Singapore (1997-2002) and Hong Kong (2002-2003). For his achievements and contributions, he is elected a fellow of professional societies in the UK, Hong Kong, USA and internationally (FIMMM, 2001; FIMechE, 2007; FHKIE, 2010; FBSE, 2011; FAIMBE, 2012; WAC Academician, 2013; FRSC, 2020). His research interests include biomedical materials, tissue engineering, controlled release, and bionanotechnology. He has authored a large number of publications in peer-reviewed journals, books and conference proceedings. He has given many conference presentations, including over 190 invited talks at international conferences. He and his team have won many awards at international conferences. He has been developing new biomaterials using the composite/hybridization approach since 1991 and has been conducting tissue engineering research since 1999. The seminal research on bioactive bone analogue materials for bone substitution conducted in London by him and his colleagues in the 1990s were widely reported by the press (The Times in the UK, Chinese Science News in China, etc.). He is a leading researcher internationally on biomedical composite research and his work on biomedical composites has been widely cited by researchers in many countries. Dr.Wang and co-workers have also investigated various fabrication technologies for tissue engineering scaffolds, including freeze-drying, electrospinning and 3D printing, and the scaffolds developed are used to regenerate tissues such as bone, osteochondral tissue, blood vessel, peripheral nerve and gastrointestinal tract. His group also develops new materials and mechanisms for 4D printing in tissue engineering. He has authored chapters on 3D printing for authoritative books. Dr.Wang has been the Series Editor of Springer Series in Biomaterials Science and Engineering (http://www.springer.com/series/10955) books since 2012 and Editor or Associate Editor of journals (Progress in Materials Science, Medical & Biological Engineering & Computing, IET Nanobiotechnology, etc.). He served/serves in the Editorial Board of more than 20 international journals, including Journal of Materials Science: Materials in Medicine, Composites Science and Technology, Biomedical Materials, Biomaterials Research, and Journal of Orthopaedic Translation. Dr.Wang has served as Chair/Co-Chair and/or Organizer/Co-Organizer of 29 international conferences/symposia/workshops, including symposium/workshop in four World Biomaterials Congresses. Dr.Wang was/is an elected Council Member of Hong Kong Institution of Engineers, Chinese Society for Biomaterials (CSBM), Asian Biomaterials Federation, World Association for Chinese Biomedical Engineers (WACBE), and International Federation for Medical and Biological Engineering (IFMBE). Currently, he is also an elected member of the Steering Committee and Treasurer of IUS-BSE’s International College of Fellows.

Christine Knabe
(Philipps University Marburg, Germany)

Professor Christine Knabe is Professor of Experimental Orofacial Medicine at the dental school of the Philipps University Marburg, Germany. The focus of her work is on translational research from bench to bedside in the context of clinically relevant subjects in regenerative medicine and biomaterials research. Her research deals with various aspects of regenerative medicine, bone regeneration and bone tissue engineering utilizing bioactive resorbable bone grafting materials and 3D printed bioactive ceramic scaffolds in combination with 3D perfusion stem cell culture and microvascular techniques for segmental defect repair mainly in the context of implant dentistry and orthopaedics. From 1999 on, Professor Knabe built her own independent research program, specifically focusing on cellular reaction pathways triggered by the presence of bioactive implant materials and on translational research, which takes new biomaterials and therapeutic concepts for bone and tissue regeneration from basic research via preclinical studies involving large animal models and clinical trials to the clinical arena. These studies led to the FDA approval and clinical use of a novel bioactive silica containing calcium orthophosphate bone grafting material. Professor Knabe’s work furthermore deals with the effect of host factors on craniofacial bone regeneration with bioactive calcium phosphate bone grafts. This is in addition to collaborating with colleagues at University of Pennsylvania in the pursuit of much better treatments of resistant infections and with colleagues of the UNC at Charlotte on novel bioceramic urethral bulking agents.
Prof. Knabe obtained her DDS at the University of Göttingen, Germany, in 1988, and her PhD with Professor U. Gross in Berlin, Germany. After training in Oral Surgery and Periodontology at the University of Tübingen, she joined the Department of Prostodontics at the Free Universität Berlin in 1992. She complemented her training by various study periods abroad. In 1993, with Professor J. E. Davies at the University of Toronto, Canada; and in 1994. with Professor U. Belser at the University of Geneva, Switzerland, in clinical implant dentistry. From 1992-2010, she held various positions with increasing responsibilities in the departments of Prosthodontics (1992-1996), Periodontology (1996-1997), and was director of the division of Biomaterials and Dental Materials of the Dept. of Experimental Dentistry (1997-2010) at the Charité University Medical Center. 1999-2000 she spent a sabbatical with Prof. Rolfe Howlett at the Bone Biomaterial Unit of the University of New South Wales in Sydney, Australia to study molecular biological issues regarding implant-tissue interactions. Since 2007 she also has been visiting associate professor at the Division of Orthopaedic Surgery of the Thomas Jefferson University in Philadelphia (Director Prof. I. Shapiro). In January 2011, she joined the Philipps University Marburg, where she chairs the department of Experimental Orofacial Medicine. A very recent honor received by Professor Knabe from the Charité Foundation is the appointment as BIH (Berlin Institute of Health) visiting professor. In this context, Prof. Knabe closely collaborates with colleagues at the Charité University Medical Center and the Federal Institute for Materials Research in the pursuit of tissue engineered approaches for reconstruction of large segmental mandibular discontinuity defects resulting from tumor ablation.

Ahmed El-Ghannam
(University of North Carolina at Charlotte, USA)

Dr. El-Ghannam is a highly creative biomaterials engineer with several US patents on the design of novel bioactive resorbable ceramics, coating bioceramics on Titanium and cobalt-chromium alloy and additive manufacturing of SiC and SCPC for space, military, and medical applications. The laboratory of Dr. EL-Ghannam got funds from DePuy J&J company, North Carolina Biotechnology center, DoD, NASA and others. Dr. El-Ghannam has successfully taken a novel resorbable bioactive ceramic (Shefabone SCPC) from the laboratory bench to the surgery room through FDA approval. He has many collaborators from universities, industry and medical institutes in US and worldwide. Dr. El-Ghannam has been a keynote speaker and a chair in national and international biomaterials conferences and has served as the associate editor of the JBMR-A for the last 16 years. He authored and co-authored biomaterials books and book chapters and have many publications in biomedical materials, engineering, dental and orthopedic journals. He was recognized recently by Stanford University in the list of the top 2% most widely cited scientists in Bioengineering.

Kyu Sang Joeng
(McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, USA)

Dr. Joeng has been an assistant professor in the Department of Orthopaedic Surgery at the University of Pennsylvania since 2018. Before Penn, he received his bachelor's in Biology from Yonsei University in 2000 and worked two more years at Yonsei University for a Master's Degree. He worked with Dr. Fanxin Long for his Ph.D. at Washington University in Saint Louis and joined Dr. Brendan Lee's lab for his postdoctoral training. The overall goal of his research program is to understand the pathophysiological mechanisms of musculoskeletal disorders, particularly related to the joint, such as osteoarthritis and tendon/ligament disorders.

Jung-Taek Hwang
(Department of Orthopedic Surgery, Cuncheon Sacred Heart Hospital, Hallym University Medical College, Korea, Republic of)

I am a specialist in shoulder and elbow Surgery, sports medicine, and arthroscopy. And I am interested in musculoskeletal biomechanics, regenerative medicine, and postoperative pain control.

Atsushi Mahara
(Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Japan)

My name is Atsushi Mahara. I was born in Japan and am now a Laboratory Chief at the National Cerebral and Cardiovascular Center Research Institute. When I was in the university, my research focused on nucleic acid chemistry and photoanalytical chemistry. After that, in my professional career, I have studied and developed cardiovascular devices based on tissue engineering and imaging technology. Especially, I have been interested in the preclinical application of decellularized artificial blood vessels and supramolecular MR contrast agents. I received the Young Investigation Award from the Japanese Society for Regenerative Medicine and the Society for Artificial Organs. My recent hobbies are reading, listening to and playing music, and walking with my dog.

Atsushi Mahara
(Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Japan)

My name is Atsushi Mahara. I was born in Japan and am now a Laboratory Chief at the National Cerebral and Cardiovascular Center Research Institute. When I was in the university, my research focused on nucleic acid chemistry and photoanalytical chemistry. After that, in my professional career, I have studied and developed cardiovascular devices based on tissue engineering and imaging technology. Especially, I have been interested in the preclinical application of decellularized artificial blood vessels and supramolecular MR contrast agents. I received the Young Investigation Award from the Japanese Society for Regenerative Medicine and the Society for Artificial Organs. My recent hobbies are reading, listening to and playing music, and walking with my dog.

Yuji Teramura
(Cellular and Molecular Biotechnology Research Institute (CMB), National Institute of Advanced Industrial Science and Technology, Japan)

Yuji Teramura is a researcher over 18 years of experience in an interdisciplinary research area of engineering and medicine since he received Ph.D. With his research background in polymer chemistry, he has contributed to biomedical research projects such as bioartificial pancreas, and cell- and organ-transplantation. Currently, he is a Chief Senior Researcher in National Institute of Advanced Industrial Science and Technology (AIST) in Tsukuba, Japan and also appointed as Professor in University of Tsukuba and Uppsala University in Sweden. He is also a co-founder of a pharmaceutical company developing novel therapeutics for cell and organ transplantation.

Alireza Biglarnia
(Lund University, Sweden)

Dr. Biglarnia is an adjunct lecturer at Lund University and the medical director at the Department of Transplantation at Skåne University Hospital in Malmö, Sweden. His pre-clinical and clinical research is currently focused on the role of innate immunity in the mediation of graft injury in solid organ transplantation. Beyond academia, Dr. Biglarnia is also a co-founder of a pharmaceutical company developing novel therapeutics by combining engineering techniques to address injurious innate immune responses across a variety of medical conditions.

Naoki Morimoto
(Department of Plastic and Reconstructive Surgery, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Japan)

2019.5-present Professor, Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University
2016.12-2019.4 Associate professor, Department of Plastic and Reconstructive Surgery, Kansai Medical University
2011.4-2016.11　Senior Lecturer, Department of Plastic and ReconstructiveSurgery, Kansai Medical University
2005.4 Ph.D. Kyoto University Graduate School of Medicine
2004.4 –2011.3 Assistant professor, Department of Plastic and Reconstructive Surgery, Kyoto University
2003.4-2004.3 Fellow, Department of Plastic and Reconstructive Surgery, Kyoto University
2000.4-2003.3 Regular surgical staff, Kobe Municipal General Hospital
1998.3-2000.3 Fellow, Department of Plastic and Reconstructive Surgery, , Kyoto University
1996.4-1998.2 Regular surgical staff, Shimane Prefectural Central Hospital
1994.12-1996.3 Resident, Department of Plastic and Reconstructive Surgery, Shimane Prefectural Central Hospital
1993.5-1994.12 Resident, Department of Plastic and Reconstructive Surgery, Kobe Municipal General Hospital
1993.3 Graduated from Kyoto University School of Medicine

Yuji Teramura
(Cellular and Molecular Biotechnology Research Institute (CMB), National Institute of Advanced Industrial Science and Technology, Japan)

Yuji Teramura is a researcher over 18 years of experience in an interdisciplinary research area of engineering and medicine since he received Ph.D. With his research background in polymer chemistry, he has contributed to biomedical research projects such as bioartificial pancreas, and cell- and organ-transplantation. Currently, he is a Chief Senior Researcher in National Institute of Advanced Industrial Science and Technology (AIST) in Tsukuba, Japan and also appointed as Professor in University of Tsukuba and Uppsala University in Sweden. He is also a co-founder of a pharmaceutical company developing novel therapeutics for cell and organ transplantation.

Arthur J. Coury
(Northeastern University, USA)

Arthur (Art) J. Coury
Member, National Academy of Engineering
American Chemical Society Fellow
University Distinguished Professor of Chemical Engineering
Northeastern University
artjcoury@aol.com
a.coury@northeastern.edu
617-834-9179

Dr. Art Coury holds a B.S. degree in chemistry from the University of Delaware (1962), a Ph.D. in organic chemistry (1965) and an M.B.A. (1980) from the University of Minnesota. His industrial career included positions as: Senior Research Chemist at General Mills, Inc. (1965-‐1976), Director, Polymer Technology and Research Fellow at Medtronic, Inc. (1976‐1993), Vice President, Research and Chief Scientific Officer at Focal, Inc. (1993‐2000), and Vice President, Biomaterials Research at Genzyme Corporation (2000‐2008). He currently is a consultant and academic professor. His career focus has been polymeric biomaterials for medical products such as implantable electronic devices, hydrogel‐based devices, and drug delivery systems. He holds over fifty-seven distinct patents and has published and presented widely in his field. His prior or current academic service has included adjunct or affiliate appointments at the University of Minnesota, the Harvard‐MIT Graduate Program in Health Sciences and Technology, the University of Cape Town, South Africa, the University of Trento, Italy, Sichuan University, China, Hebei University, China, and Northeastern University. His professional service has included: Chair, Minnesota Section, American Chemical Society (1989‐1990); President, Society for Biomaterials, USA (1999‐2000); President, American Institute for Medical and Biological Engineering (AIMBE) (2003‐2004) and membership on several universities, professional societies, and corporate advisory boards. His recent recognitions have included the delivery of distinguished lectureships, receipt of the 2007 Innovation and Technology Development Award of the Society for Biomaterials, being named as one of “100 Notable People in the Medical Device Industry” by MD&DI magazine (2008), induction into the National Academy of Engineering, USA (2009), recognition on the University of Delaware alumni “Wall of Fame” (2010), “The Man, the Myth, the Materials”, a symposium in honor of Art Coury’s 70th birthday (2010), induction as an American Chemical Society Fellow (2011), recipient of the Society for Biomaterials Founders’ Award (2012) and its C. William Hall Award (2013) of the AIMBE Pierre Galletti Award, the University of Minnesota Outstanding Alumni Award (2013), appointment as Honorary Professor, Sichuan University, Chengdu, China (2013) and Hebei University, Tianjin, China (2019), University Distinguished Professor at Northeastern University (2014), and recognition with the Directors’ Award of the Harvard/MIT Joint Program in Health Sciences and Technology (2016). A joint U.S/Japan Society for Biomaterials Symposium was held to honor 2 American and 2 Japanese Biomaterials Leaders in Hawaii (January 2022), with Art being an Honoree. In April, 2023, Art received the Society for Biomaterials Service Award and the American Chemical Society Division of Rubber Chemistry Bioelastomer Award.

Suping Lyu
(Medtronic Inc., USA)

Scientist at Medtronic PLC since 2020, expertise in polymer materials for medical devices.

James Moon
(University of Michigan, Ann Arbor, USA)

Dr. James Moon is John Gideon Searle Professor in the Department of Pharmaceutical Sciences, Biomedical Engineering, and Chemical Engineering at the University of Michigan, Ann Arbor. His interdisciplinary research program aims to develop novel biomaterials-based strategies to advance fundamental understanding of the immune system, with the ultimate goal of improving patients’ lives with effective vaccines and immunotherapies. Dr. Moon has published over 120 research articles, including those published in Nature Materials, Nature Medicine, Nature Nanotechnology, Nature Biomedical Engineering, Nature Reviews Materials, and Science Translational Medicine. He has over 20 pending/approved U.S. and international patent applications, and his novel nano-vaccine delivery technologies have led to 3 new start-up companies (EVOQ Therapeutics, Saros Therapeutics, and Elicio Therapeutics). Dr. Moon is a fellow of BMES, AIBME, and CRS, and his contributions to the field has been recognized with numerous awards, including NSF CAREER Award and Samyang CRS Award. Dr. Moon received his bachelor’s degree from the University of California, Berkeley (2002), and his Ph.D. from Rice University (2008), and he completed his postdoctoral training at MIT. He joined the faculty of the University of Michigan in 2012.

James Wabby
(Regulatory Affairs (CoE), AbbVie, Inc, USA)

James is responsible for leading global regulatory affairs for AbbVie’s device and medicinal/device delivery portfolio providing the vision for the future of device at AbbVie and in the broader industry.
James has 22 years of experience in increasing regulatory compliance and regulatory affairs responsibilities within the GxP regulated environment pertaining to Medical Devices, Medicinal Delivery Platforms, Companion Diagnostics, Digital Medicine, and Combination Product areas. He regularly provides AbbVie therapeutic franchise units regulatory counsel and strategy to all aspects within the quality management system and regulatory affairs.
James is an internationally recognized leader as he is a member of various regulatory/quality work groups and is a speaker and keynote at various regulatory symposia. In addition, he is the Chair of the DIA Combination Products Committee, Chair of the ISPE Combination Products (CoP), and a moderator for various global regulatory panel discussions.

James holds a BSc. in Biology from Duquesne University, MHMS in Health Law and Policy from Duquesne University, Certificate in Health Law and Life Science Regulatory Compliance from Seton Hall University Law School - Center for Health & Pharmaceutical Law, and Certificate, RAPS Executive Development Program from Northwestern University - Kellogg School of Management.

Takahiro Ochiya
(Tokyo Medical University, Japan)

Dr. Takahiro Ochiya was a Chief of Division of Molecular and Cellular Medicine at the National Cancer Center Research Institute, Tokyo since 2010 and he is currently appointed as professor of Tokyo Medical University (since 2018). After he got Ph.D. in 1988 in Osaka University and then went to do a post-doc at La Jolla Cancer Research (SF Burnham Institute for Medical Research), CA, USA. Dr. Ochiya’s lab focuses the development of novel animal models, methods, and strategies to study cancer development and metastasis. Especially, current focuses are siRNA- and microRNA-based therapy against cancer stem cells. Dr. Ochiya is a leading scientist in extracellular vesicles research in cancer area and carries president of Japanese Society of Extracellular Vesicles (JSEV) since 2014. He is also carrying as ISEV board member (education committee) since 2020. Dr. Ochiya awarded as Highly Cited Researchers in the Web of Science in 2019~ 2023.

Jinmyoung Joo
(Ulsan National Institute of Science and Technology, Korea, Republic of)

Jinmyoung Joo is currently an Associate Professor of Biomedical Engineering at the Ulsan National Institute of Science and Technology (UNIST), where he holds affiliate appointments in the Chemical Engineering and Graduate School of Health Science and Technology. He received B.S. (2007) and Ph.D. (2012) degrees in Chemical Engineering from POSTECH, and then worked as a postdoctoral research associate in the Department of Chemistry and Biochemistry at University of California, San Diego. He started his independent career as an Assistant Professor in the Department of Convergence Medicine at the University of Ulsan College of Medicine in 2016, and joined the faculty of the Biomedical Engineering at the UNIST in 2019. He has been interested in understanding the interaction of nanomaterials with complex biological systems, engineering novel nanostructures that can effectively understand tissue microenvironment and target diseases such as cancer, neurodegenerative diseases, and tissue regeneration. His lab has focuses on leveraging nanoscale materials to study biological findings and to bridge them to translational medical platforms such as bioimaging and drug delivery systems.

Jinmyoung Joo
(Ulsan National Institute of Science and Technology, Korea, Republic of)

Jinmyoung Joo is currently an Associate Professor of Biomedical Engineering at the Ulsan National Institute of Science and Technology (UNIST), where he holds affiliate appointments in the Chemical Engineering and Graduate School of Health Science and Technology. He received B.S. (2007) and Ph.D. (2012) degrees in Chemical Engineering from POSTECH, and then worked as a postdoctoral research associate in the Department of Chemistry and Biochemistry at University of California, San Diego. He started his independent career as an Assistant Professor in the Department of Convergence Medicine at the University of Ulsan College of Medicine in 2016, and joined the faculty of the Biomedical Engineering at the UNIST in 2019. He has been interested in understanding the interaction of nanomaterials with complex biological systems, engineering novel nanostructures that can effectively understand tissue microenvironment and target diseases such as cancer, neurodegenerative diseases, and tissue regeneration. His lab has focuses on leveraging nanoscale materials to study biological findings and to bridge them to translational medical platforms such as bioimaging and drug delivery systems.

Michael J. Sailor
(University of California San Diego, USA)

Michael J. Sailor is Distinguished Professor at the University of California, San Diego, Director of the UC San Diego Materials Research Science and Engineering Center (an NSF MRSEC), and Director of the UC San Diego Institute for Materials Discovery & Design. He holds Affiliate Appointments in the UCSD Bioengineering Department, the Nanoengineering Department, and the Materials Science and Engineering program. He was trained at Harvey Mudd College (BS Chemistry), Northwestern University (PhD Chemistry), Stanford (Post-doctoral), and Caltech (Post-doctoral). He has supervised more than 160 undergraduate, graduate, and post-doctoral students, he is the author of more than 260 peer-reviewed research publications, one book, and 39 issued patents. He has an H-Index (Google Scholar) of 100. He has founded or co-founded four companies, including Lisata Therapeutics (NASDAQ: LSTA). He is an elected Fellow of the American Association for the Advancement of Science, the U.S. National Academy of Inventors, and the Royal Society of Chemistry, and he serves as Associate Editor of the journal ACS Sensors.

Hyunwoo Yuk
(SanaHeal, USA)

Dr. Hyunwoo Yuk received a Ph.D. / M.S. in Mechanical Engineering at the Massachusetts Institute of Technology in 2021/2016, and a B.S. from the Korea Advanced Institute of Science and Technology in 2014, both in Mechanical Engineering. Dr. Yuk is currently the CTO of a medtech startup, SanaHeal, Inc., which he founded in 2021. His research focuses on the broad topics of mechanics and materials science and engineering in human–machine interfaces including robust adhesion of soft materials, hydrogel bioelectronics, and 3D printing of advanced soft materials. He is a recipient of various prestigious awards including the Materials Research Society Graduate Student Award, Forbes 30 Under 30, and MIT Technology Reviews Innovators Under 35.

Alec Smith
(University of Washington, USA)

Dr. Alec Smith is a Research Assistant Professor in the Department of Physiology and Biophysics at The University of Washington. Dr. Smith earned his Ph.D. in Tissue Engineering from University College, London (UK) in 2012 before moving to the United States to pursue a career in biomedical research. His expertise includes electrophysiology, molecular biology, and tissue engineering, with a particular focus on muscle and neuronal tissues. His work has involved the development of novel 2D and 3D culture systems for assessing nerve and muscle performance, and the analysis of physiological interactions between multiple cell types in vitro. By integrating human tissue engineering and cell culture with advanced methods for assaying electrophysiological and contractile function, he aims to develop novel platforms with which to improve the predictive capacity of current preclinical toxicity screening and disease modeling technologies. To date, Dr. Smith has authored or co-authored more than 50 peer-reviewed journal articles and referenced conference proceedings, as well as 5 book chapters, and his papers have been cited over 2,700 times. In addition, he has filed 3 patents (issued or pending) based on his research. Over the course of his career so far, Dr. Smith has been the recipient of a number of awards, including The UK Medical Research Council Doctoral Training Award (2007), The Jaconette L. Tietze Young Scientist Award (2017), The University of Washington’s Institute for Translational Health Science KL2 Career Development Award (2017), and the Weill Neurohub Investigator Award (2023).

Eun Je Jeon
(Cellartgen, Korea, Republic of)

Eun Je Jeon currently serves as the team leader in the Advanced Biomaterials Research and Development Department at Cellartgen Inc. in the Republic of Korea. She earned her B.S. degree from the College of Natural Sciences at Seoul Women's University in 2013 and later obtained her Ph.D. in Biotechnology from Yonsei University. In 2022, she joined Cellartgen Inc. as a Senior Researcher and was appointed team leader for Advanced Biomaterials Research and Development in 2023. She has also been selected as a Junior Researcher in the Ministry of SMEs and Startups since May 2023. Her research interests focus on utilizing functional biomaterials for tissue engineering, particularly in the areas of stem cells, reprogrammed cells, and organoids. She has published 19 peer-reviewed papers with over 754 citations and obtained more than 17 filed patents and pending patent applications. Recognized for her outstanding contributions, she received the KSBM-KOFWST Young Scientist Award from the Korean Society for Biomaterials and the WBF-Biosolution Saebyeol Women's Science Award from the Women's Bioscience Forum in 2021.

Sandra Van Vlierberghe
(Ghent University, Belgium)

Sandra Van Vlierberghe (10-07-1981) was granted a full-time professorship at UGent since October 1st, 2017. Her research targets to establish at UGent, “a polymer-based technological platform covering processing and functionalization aspects sufficiently versatile to potentially address a wide range of tissue engineering (TE) challenges by exploiting the unique properties of light.” Indeed, her research focusses on the development of photo-crosslinkable (bio)polymers and their processing capabilities using 3D printing techniques. She has acquired expertise related to the synthesis, the modification and the processing (through extrusion-based 3D printing, electrospinning and light-based 3D-printing (two-photon polymerization (2PP), digital light projection (DLP) and volumetric printing) of a variety of (bio)polymers including thermoplasts (e.g. polyesters) and hydrogels (e.g. proteins and polysaccharides) in the field of regenerative medicine during the past 15 years. She graduated as a Master in Chemistry with high distinction with majors in Polymer Chemistry in 2003 and received her PhD in Sciences in 2008, both at Ghent University. She authored more than 235 Web of Science Core Collection cited papers of which 195 high impact journal papers (one with an impact factor of 42.846) and 16 full papers in international conference proceedings. In addition, she also authored more than 200 conference abstracts. She has a h-index of 44 (WoS) and is promoter of 23 PhD’s (in addition to 15 defended PhD’s), she edited three books, authored 7 chapters in books of which 5 invited and was invited speaker at > 15 international conferences and keynote as well as plenary speaker at 15 international conferences. She is treasurer of the Belgian Polymer Group (BPG), she was spokesperson of the YSF which is affiliated to the ESB and she is secretary of the Belgian Society for Tissue Engineering (BSTE). She is TERMIS-EU council member since 2019 and ESB council member since 2021. She is also founding board member of GATE (Ghent Alliance for Advanced Therapies and Tissue Engineering). Since 2020, she serves on the Board of Directors of the Fernand Lazard Foundation. Sandra is also editorial board member of the Biomaterials Network, associate editor of Journal of Materials Science: Materials in Medicine and of Frontiers in Bioengineering and Biotechnology (editor-in-chief of Biofabrication section), academic guest editor of Materials, editorial advisory board member of Hydrogels and editorial board member of Biomedical Materials, Journal of Nanomedicine and Nanotechnology and Journal of Applied Biomaterials and Functional Materials. She has also been active in project reviewing and as panel member (e.g. 3 x panel member of ERC StG). In 2017, she received the Jean Leray Award from the European Society for Biomaterials (ESB). This award is established to recognize outstanding research in the field of biomaterials by scientists not older than 40 years. In 2020 and 2021, she also served on the Independent Awards Committee of ESB. She is co-founder of spin-offs BIO INX and 4Tissue Laboratory.

Sandra Van Vlierberghe
(Ghent University, Belgium)

Sandra Van Vlierberghe (10-07-1981) was granted a full-time professorship at UGent since October 1st, 2017. Her research targets to establish at UGent, “a polymer-based technological platform covering processing and functionalization aspects sufficiently versatile to potentially address a wide range of tissue engineering (TE) challenges by exploiting the unique properties of light.” Indeed, her research focusses on the development of photo-crosslinkable (bio)polymers and their processing capabilities using 3D printing techniques. She has acquired expertise related to the synthesis, the modification and the processing (through extrusion-based 3D printing, electrospinning and light-based 3D-printing (two-photon polymerization (2PP), digital light projection (DLP) and volumetric printing) of a variety of (bio)polymers including thermoplasts (e.g. polyesters) and hydrogels (e.g. proteins and polysaccharides) in the field of regenerative medicine during the past 15 years. She graduated as a Master in Chemistry with high distinction with majors in Polymer Chemistry in 2003 and received her PhD in Sciences in 2008, both at Ghent University. She authored more than 235 Web of Science Core Collection cited papers of which 195 high impact journal papers (one with an impact factor of 42.846) and 16 full papers in international conference proceedings. In addition, she also authored more than 200 conference abstracts. She has a h-index of 44 (WoS) and is promoter of 23 PhD’s (in addition to 15 defended PhD’s), she edited three books, authored 7 chapters in books of which 5 invited and was invited speaker at > 15 international conferences and keynote as well as plenary speaker at 15 international conferences. She is treasurer of the Belgian Polymer Group (BPG), she was spokesperson of the YSF which is affiliated to the ESB and she is secretary of the Belgian Society for Tissue Engineering (BSTE). She is TERMIS-EU council member since 2019 and ESB council member since 2021. She is also founding board member of GATE (Ghent Alliance for Advanced Therapies and Tissue Engineering). Since 2020, she serves on the Board of Directors of the Fernand Lazard Foundation. Sandra is also editorial board member of the Biomaterials Network, associate editor of Journal of Materials Science: Materials in Medicine and of Frontiers in Bioengineering and Biotechnology (editor-in-chief of Biofabrication section), academic guest editor of Materials, editorial advisory board member of Hydrogels and editorial board member of Biomedical Materials, Journal of Nanomedicine and Nanotechnology and Journal of Applied Biomaterials and Functional Materials. She has also been active in project reviewing and as panel member (e.g. 3 x panel member of ERC StG). In 2017, she received the Jean Leray Award from the European Society for Biomaterials (ESB). This award is established to recognize outstanding research in the field of biomaterials by scientists not older than 40 years. In 2020 and 2021, she also served on the Independent Awards Committee of ESB. She is co-founder of spin-offs BIO INX and 4Tissue Laboratory.

Insup Noh
(Seoul National University of Science and Technology, Korea, Republic of)

Insup Noh is a professor at the Department of Chemical and Biomolecular Engineering and a chief professor/founder of the Convergence Institute of Biomedical Engineering and Biomaterials of Seoul National Univ. of Science & Technology (Korea). After both receiving his MS and Ph.D. degrees in the areas of biomaterials for tissue engineering from the Univ. of Texas at Austin (1994) and working at the California Institute of Technology(Caltech, 1995-1997) as a special graduate student under J.A. Hubbell, he had done researches with E.R. Edelman in the division of Harvard-MIT Health Science and Technology as a postdoctoral researcher for local drug delivery in cardiovascular diseases(1997-1999). Professor Insup Noh’s expertise lies in the area of functional biomaterials for bone and cartilage tissue engineering by using in situ 3D bioprining technology with diverse bioinks. He served the president of the Korean Society for Biomaterials(2020) and the editor-in-chief of Biomaterials Research (2012-2019, Springer-Nature, UK) and is the president/founder of MatrixCellBio Inc., Korea, and a IUSBSE KSBM delegate.

Jasper Van Hoorick
(BIO INX, Belgium)

Jasper Van Hoorick graduated as master in Chemistry in 2014 with a major in Molecular and Macromolecular design and a minor in Industry and Management. In his master thesis he focussed on the development of materials for tissue engineering purposes for which he received the 2014 Agoria award for technological master dissertations as part of the Vlaamse Scriptieprijs. Thanks to this award he completed an executive masterclass in Innovation and Entrepreneurship at Vlerick business school in 2015. In 2015 he secured funding from the FWO (Research Foundation Flanders) for a joint PhD project between the Polymer Chemistry & Biomaterials Research group (PBM) at Ghent University and Brussels Photonics (B-PHOT) at the Vrije Universiteit Brussel. In his PhD he focussed on the development of novel biodegradable polymer materials and their processing into membranes for ocular tissue regeneration thereby taking advantage of (high resolution) additive manufacturing using laser based multiphoton lithography 3D printing (2PP). He co-authored over 30 Web of Science Core Collection cited papers, 1 book chapter and co-edited one book. Additionally, he attended multiple international conferences to present the results he obtained during his PhD, and obtained funding for 5 international research stays in Vienna, Austria (Prof. Dr. Aleksandr Ovsianikov) to perform 2PP experiments. Finally, the work performed during his PhD also resulted in the filing of 2 patents. In 2018 he aided in consolidating FWO funding thereby aiming to further develop the corneal membranes towards (pre)clinical applications. In 2019 he completed his PhD with greatest honours for which he was awarded a Solvay award in 2020 and a Julia Polak Award in 2021. Additionally, he was a finalist in the Flemish PhD cup in 2021. After his PhD, he secured funding for a post-doc position at Ghent University towards the preparation of a spin-off company. In 2022, the spin-off company BIO INX was launched, which he leads as CEO. BIO INX focusses on the development and commercialisation of biomaterials and bio inks for 3D bioprinting with applications in regenerative medicine. It made the finals of the 2022 RSC Emerging Technologies Competition in 2022 and was elected in 2023 as UNIZO East-Flanders Start-up of the year.

Yong Woo Cho
(Hanyang University, Korea, Republic of)

Yong Woo CHO PhD is a Professor, Department of Materials Science and Chemical Engineering, Hanyang University ERICA and CEO of ExoStemTech Inc, South Korea. He got BS, MS, and PhD degrees from School of Engineering, Seoul National University. He worked for KIST (Korea Institute for Science and Technology) and Purdue University as a Post Doc. Since 2006, he has been working for Hanyang University ERICA. His research interest is exosome-based therapeutics, focused on regenerative medicine using stem cell exosomes and exosome-based protein/RNA delivery systems. In 2016, he founded a bio-venture company, ExoStemTech Inc., for the clinical development of exosome therapeutics and is currently developing several exosome products for the treatment of osteoarthritis, tendinitis, lung fibrosis, Parkinson’s disease, etc.

Chris Wattengel
(Collagen Solutions, United Kingdom)

Chris Wattengel is Global Vice President of R&D for Collagen Solutions. He is a seasoned medical device industry innovator and leader with over 20 years of experience in product and business development. He has led R&D teams from concept through commercialization, and been involved with bringing over 10 product families to market.

Insup Noh
(Seoul National University of Science and Technology, Korea, Republic of)

Insup Noh is a professor at the Department of Chemical and Biomolecular Engineering and a chief professor/founder of the Convergence Institute of Biomedical Engineering and Biomaterials of Seoul National Univ. of Science & Technology (Korea). After both receiving his MS and Ph.D. degrees in the areas of biomaterials for tissue engineering from the Univ. of Texas at Austin (1994) and working at the California Institute of Technology(Caltech, 1995-1997) as a special graduate student under J.A. Hubbell, he had done researches with E.R. Edelman in the division of Harvard-MIT Health Science and Technology as a postdoctoral researcher for local drug delivery in cardiovascular diseases(1997-1999). Professor Insup Noh’s expertise lies in the area of functional biomaterials for bone and cartilage tissue engineering by using in situ 3D bioprining technology with diverse bioinks. He served the president of the Korean Society for Biomaterials(2020) and the editor-in-chief of Biomaterials Research (2012-2019, Springer-Nature, UK) and is the president/founder of MatrixCellBio Inc., Korea, and a IUSBSE KSBM delegate.

Insup Noh
(Seoul National University of Science and Technology, Korea, Republic of)

Insup Noh is a professor at the Department of Chemical and Biomolecular Engineering and a chief professor/founder of the Convergence Institute of Biomedical Engineering and Biomaterials of Seoul National Univ. of Science & Technology (Korea). After both receiving his MS and Ph.D. degrees in the areas of biomaterials for tissue engineering from the Univ. of Texas at Austin (1994) and working at the California Institute of Technology(Caltech, 1995-1997) as a special graduate student under J.A. Hubbell, he had done researches with E.R. Edelman in the division of Harvard-MIT Health Science and Technology as a postdoctoral researcher for local drug delivery in cardiovascular diseases(1997-1999). Professor Insup Noh’s expertise lies in the area of functional biomaterials for bone and cartilage tissue engineering by using in situ 3D bioprining technology with diverse bioinks. He served the president of the Korean Society for Biomaterials(2020) and the editor-in-chief of Biomaterials Research (2012-2019, Springer-Nature, UK) and is the president/founder of MatrixCellBio Inc., Korea, and a IUSBSE KSBM delegate.

Xiumei Wang
(Tsingua University, China)

Prof. Xiumei Wang is currently a professor at the school of Materials Science and Engineering, Tsinghua University. She obtained her Ph.D. degree in Materials Science and Engineering at Tsinghua University, China, in 2005, and continued her postdoctoral fellow at the University of Rochester and Massachusetts Institute of Technology, MA, USA from 2005 to 2008. She started her professional career in School of Materials Science and Engineering at Tsinghua University from 2008. Her researches mainly focus on biomaterial-based multimodal tissue engineering strategy for tissue regeneration. She has developed a series of bioactive biomaterials based on biomimetic strategy for tissue regeneration (nerve, bone, and cartilage) and clinical translation. She published more than 200 SCI papers, filed 20 patents, several books and book chapters. She is the executive member of the Chinese Society for Biomaterials and served the co-Editor-in-Chief of Tissue Engineering-Part C and the editorial member of Frontier of Materials Science, Regenerative Biomaterials, Biomaterials Research. She was honored "Gold Medal AFJ Award" and "Gold Medal Award" at the 2023 International Exhibition of Inventions of Geneva, “Second Prize of the State Natural Science Award” by the State Council of the P.R. China (2011), “First Prize of Chinese Medical Science and Technology Award” by the Chinese Medical Association (2021), First Prize in Science and Technology of Chinese Materials Research Society (2021), “First Prize of Shandong Province Science and Technology Progress Award” (2014), 2012 Distinguished Young Scholar of Tsinghua University, and 2013 New Century Excellent Talents by the Ministry of Education of China.

Sandra Van Vlierberghe
(Ghent University, Belgium)

Sandra Van Vlierberghe (10-07-1981) was granted a full-time professorship at UGent since October 1st, 2017. Her research targets to establish at UGent, “a polymer-based technological platform covering processing and functionalization aspects sufficiently versatile to potentially address a wide range of tissue engineering (TE) challenges by exploiting the unique properties of light.” Indeed, her research focusses on the development of photo-crosslinkable (bio)polymers and their processing capabilities using 3D printing techniques. She has acquired expertise related to the synthesis, the modification and the processing (through extrusion-based 3D printing, electrospinning and light-based 3D-printing (two-photon polymerization (2PP), digital light projection (DLP) and volumetric printing) of a variety of (bio)polymers including thermoplasts (e.g. polyesters) and hydrogels (e.g. proteins and polysaccharides) in the field of regenerative medicine during the past 15 years. She graduated as a Master in Chemistry with high distinction with majors in Polymer Chemistry in 2003 and received her PhD in Sciences in 2008, both at Ghent University. She authored more than 235 Web of Science Core Collection cited papers of which 195 high impact journal papers (one with an impact factor of 42.846) and 16 full papers in international conference proceedings. In addition, she also authored more than 200 conference abstracts. She has a h-index of 44 (WoS) and is promoter of 23 PhD’s (in addition to 15 defended PhD’s), she edited three books, authored 7 chapters in books of which 5 invited and was invited speaker at > 15 international conferences and keynote as well as plenary speaker at 15 international conferences. She is treasurer of the Belgian Polymer Group (BPG), she was spokesperson of the YSF which is affiliated to the ESB and she is secretary of the Belgian Society for Tissue Engineering (BSTE). She is TERMIS-EU council member since 2019 and ESB council member since 2021. She is also founding board member of GATE (Ghent Alliance for Advanced Therapies and Tissue Engineering). Since 2020, she serves on the Board of Directors of the Fernand Lazard Foundation. Sandra is also editorial board member of the Biomaterials Network, associate editor of Journal of Materials Science: Materials in Medicine and of Frontiers in Bioengineering and Biotechnology (editor-in-chief of Biofabrication section), academic guest editor of Materials, editorial advisory board member of Hydrogels and editorial board member of Biomedical Materials, Journal of Nanomedicine and Nanotechnology and Journal of Applied Biomaterials and Functional Materials. She has also been active in project reviewing and as panel member (e.g. 3 x panel member of ERC StG). In 2017, she received the Jean Leray Award from the European Society for Biomaterials (ESB). This award is established to recognize outstanding research in the field of biomaterials by scientists not older than 40 years. In 2020 and 2021, she also served on the Independent Awards Committee of ESB. She is co-founder of spin-offs BIO INX and 4Tissue Laboratory.

Insup Noh
(Seoul National University of Science and Technology, Korea, Republic of)

Insup Noh is a professor at the Department of Chemical and Biomolecular Engineering and a chief professor/founder of the Convergence Institute of Biomedical Engineering and Biomaterials of Seoul National Univ. of Science & Technology (Korea). After both receiving his MS and Ph.D. degrees in the areas of biomaterials for tissue engineering from the Univ. of Texas at Austin (1994) and working at the California Institute of Technology(Caltech, 1995-1997) as a special graduate student under J.A. Hubbell, he had done researches with E.R. Edelman in the division of Harvard-MIT Health Science and Technology as a postdoctoral researcher for local drug delivery in cardiovascular diseases(1997-1999). Professor Insup Noh’s expertise lies in the area of functional biomaterials for bone and cartilage tissue engineering by using in situ 3D bioprining technology with diverse bioinks. He served the president of the Korean Society for Biomaterials(2020) and the editor-in-chief of Biomaterials Research (2012-2019, Springer-Nature, UK) and is the president/founder of MatrixCellBio Inc., Korea, and a IUSBSE KSBM delegate.

Chul-Su Yang
(Hanyang University, Korea, Republic of)

Dr. Chul-Su Yang who professor of Infection Biology Lab at Dept. of Medicinal and Life Science, Hanyang University.
Research interests as below,
1. Microbial pathogenesis and host responses. (1) Molecular and cellular pathogenesis of intracellular microbes infection especially on Mycobacteria, Listeria, Candida, Toxoplasma, Influenza infection (2) Signal transduction mechanisms in immune and inflammatory responses (3) Molecular and immunopathogenesis in neuroinflammatory diseases.
2. Host-pathogen functional interactions and its therapeutic strategies. (1) The role of ROS-generating NADPH oxidases activation and expression (2) Exploring of cell death and autophagy pathways in microbial infection (3) The role of nuclear receptors in innate immunity (4) The role of mitochondria and autophagy in innate immunity.
3. Molecular engineering of Peptide-Drug Conjugates for therapeutics. (1) Peptide and protein therapeutics (2) Pharmaceutics drug delivery and targeting

In Kwon Jung
(Genoss Co., Ltd., Korea, Republic of)

In Kwon Jung is a former CEO of Genoss Company and currently serves as an advisor. He received his doctorate in polymer biomaterials from Ajou University also over 25 years of medical device industry experience in R&D, manufacturing, RA, quality management, sales, which involved in various vascular interventional devices, synthetic bone grafts, dermal fillers and dental products.

Sung-Tae Kim
(Seoul national university School of Dentistry, Korea, Republic of)

Dentist, Periodontist, Prosthodontist, Tenured professor in Seoul National University School of Dentistry and Seoul National University Dental Hospital

In Bo Han
(CHA Univ. School of Medicine, Korea, Republic of)

Dr. Inbo Han, M.D., Ph.D., is a distinguished figure in the field of neurosurgery and regenerative medicine. A proud alumnus of Yonsei University, Dr. Han further honed his expertise through a research fellowship at the esteemed Spinal Cord Injury and Stem Cell Biology Laboratory, Brigham and Women's Hospital/Harvard Medical School, USA, from 2010 to 2012. Her formative years also included a residency at Yonsei University Severance Hospital between 1997 and 2002.
Dr. Han's career progressed through various roles of increasing responsibility and impact. He has served with distinction as both an assistant and associate professor of neurosurgery at Bundang CHA Medical Center. In his current role, Dr. Han not only excels as a professor of neurosurgery but also contributes significantly as the vice dean of research director at CHA University, School of Medicine, and a director of the Advanced regenerative medicine center for Future Medicine.
Dr. Han has garnered widespread recognition for her pioneering research in regenerative therapies targeting incurable spinal diseases. His contributions to the field are evidenced by a slew of outstanding publications and a multitude of prestigious awards. Additionally, he plays a pivotal role in the Society of Neurosurgery and the Society for Regenerative Basic Science, further cementing his status as a leading authority in his field.

Terance Hart
(Maverick Biosciences, United Kingdom)

Dr Hart worked for over 30 years in Pharmaceutical Research for global companies such as Sanofi-Genzyme and Novartis as well as in many different Biotech companies, where he led teams in their discovery of new pharmaceuticals.

During the last 14 years he was for 10 years Chief Scientific Officer for Geistlich Pharma in Switzerland, where the R&D team brought through important, innovative collagen based products to the dental and tissue regeneration market, including Mucograft, Fibro-Gide and Derma-Gide. Currently he is a Scientific Advisor for Maverick Bioscience and a member of their Scientific Advisory Board.

Carlos Carvalho
(Desktop Health™, Germany)

Carlos Carvalho is the Team Leader of the Bioprinting Department at EnvisionTEC GmbH, part of the Desktop Health brand. During his PhD at the University of Freiburg, he co-authored 20 papers centered on the newly invented 3D-Bioplotter in cooperation with several german medical institutes. He contributed significant feedback to assist in the early development of the 3D-Bioplotter technology while using the first three generations of this bioprinter. Recognized for his expertise, he was invited to join EnvisionTEC to develop the 4th generation of the 3D-Bioplotter from a user-centric perspective. Under his leadership, the 3D-Bioplotter has seen continuous advancements in both hardware and software, maintaining its status for over two decades as the preferred bioprinter for academia and industry alike.

Ju Young Park
(BioBricks Co.,Ltd., Korea, Republic of)

Dr. Ju Young Park completed her Ph.D. in the Division of Integrative Biosciences & Biotechnology (IBB) at Pohang University of Science and Technology (POSTECH) in 2016. Following her doctoral studies, she worked as a postdoctoral researcher at POSTECH from 2016 to 2019 and then pursued further research training as a postdoctoral research fellow at the Biologically Inspired Engineering Systems Laboratory at the University of Pennsylvania from 2019 to 2022.
Dr. Park has made significant contributions to her field, publishing over 30 peer-reviewed papers in prestigious journals within the domains of bioprinting and tissue engineering. Presently, she holds the position of Research Director at Biobricks, a startup company dedicated to tissue engineering utilizing decellularized extracellular matrix materials and 3D bioprinting technologies. In addition to her role at Biobricks, she also serves as a Research Professor in the Department of IT Convergence Engineering at POSTECH.
Her research interests are centered around pioneering innovative therapeutic solutions for transplantation within the human body, leveraging stem cells and tissue-derived natural biomaterials, as well as cutting-edge 3D bioprinting technology.

Paul Delrot
(Readily3D, Switzerland)

Paul co-invented the volumetric bioprinting technology at the end of his PhD studies at EPFL in 2017. After transferring what was a lab experiment into a standalone and user-friendly 3D printer, Paul co-founded Readily3D in 2020. Since then, Paul has focused on demonstrating the wide range of applications enabled by volumetric bioprinting while leading product development at Readily3D.